Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-19T02:14:29.573Z Has data issue: false hasContentIssue false

Chapter 3 - Histopathology of Liver Transplantation

Published online by Cambridge University Press:  17 March 2018

Get access
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Roberts, HW, Utuama, OA, Klevens, M, Teshale, E, Hughes, E, Jiles, R. The Contribution of Viral Hepatitis to the Burden of Chronic Liver Disease in the United States. The American Journal of Gastroenterology. 2014;109(3):387–93; quiz 6, 94.Google Scholar
Asrani, SK, Larson, JJ, Yawn, B, Therneau, TM, Kim, WR. Underestimation of Liver-Related Mortality in the United States. Gastroenterology. 2013;145(2):375–82 e12.Google Scholar
Kim, WR, Therneau, TM, Benson, JT, Kremers, WK, Rosen, CB, Gores, GJ, et al. Deaths on the Liver Transplant Waiting List: An Analysis of Competing Risks. Hepatology. 2006;43(2):345–51.Google Scholar
Kim, WR, Lake, JR, Smith, JM, Skeans, MA, Schladt, DP, Edwards, EB, et al. OPTN/SRTR 2013 Annual Data Report: Liver. Am J Transplant. 2015;15 Suppl 2:128.CrossRefGoogle ScholarPubMed
Shukla, A, Vadeyar, H, Rela, M, Liver Transplantation, Shah S.: East versus West. J Clin Exp Hepatol. 2013;3(3):243–53.Google Scholar
Fung, J. Management of Chronic Hepatitis B before and after Liver Transplantation. World J Hepatol. 2015;7(10):1421–6.Google Scholar
Ghaziani, T, Sendi, H, Shahraz, S, Zamor, P, Bonkovsky, HL. Hepatitis B and Liver Transplantation: Molecular and Clinical Features that Influence Recurrence and Outcome. World J Gastroenterol. 2014;20(39):14142–55.Google Scholar
Burra, P, De Martin, E, Zanetto, A, Senzolo, M, Russo, FP, Zanus, G, et al. HCV and Liver Transplantation: Where Do We Stand? Transpl Int. 2015.CrossRefGoogle Scholar
Muir, AJ, Naggie, S. HCV Treatment: Is It Possible to Cure All HCV Patients? Clin Gastroenterol Hepatol. 2015.Google Scholar
Pipili, C, Cholongitas, E. Treatment of Chronic Hepatitis C in Liver Transplant Candidates and Recipients: Where Do We Stand? World J Hepatol. 2015;7(12):1606–16.Google Scholar
Demetris, AJ, Zeevi, A, O’Leary, JG. ABO-compatible Liver Allograft Antibody-mediated Rejection: An Update. Curr Opin Organ Transplant. 2015;20(3):314–24.CrossRefGoogle ScholarPubMed
Demetris, AJ, Crawford, JM, Isse, K, Minervini, MI, Nalesnik, MA, Rubin, E, et al. Pathology of Liver and Hematopoietic Stem Cell Transplantation. In: Odze, RD, Goldblum, JR, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1408–61.Google Scholar
Demetris, AJ, Minervini, MI, Nalesnik, MA, Randhawa, P, Sasatomi, E. Histopathology of Liver Transplantation. In: Busuttil, RW, Klintmalm, GK, editors. Transplantation of the Liver 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1112–70.Google Scholar
Demetris, AJ, Minervini, MI, Nalesnik, M, Rubin, E, Randhawa, P, Sasatomi, E. Histopathological Syndromes of Graft Rejection and Recurrent Disease: Liver. In: Kirk, A, Knechtle, S, Larsen, C, Pearson, T, Madsen, J, Webber, S, editors. Textbook of Organ Transplantation. Hoboken, NJ: Wiley-Blackwell; 2014. p. 927–56.Google Scholar
Demetris, AJ, Minervini, MI, Nalesnik, MA, Randhawa, PS, Sasatomi, E. Liver Transplantation. In: McManus, LM, Mitchell, R, editors. Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. San Diego, CA: Elsevier; 2014. p. 676–93.Google Scholar
Starzl, TE, Marchioro, TL, Von Kaulla, KN, Hermann, G, Brittain, RS, Waddell, WR. Homotransplantation of the Liver in Humans. Surg Gynecol Obstet. 1963;117:659–76.Google Scholar
Merion, RM, Goodrich, NP, Feng, S. How Can We Define Expanded Criteria for Liver Donors? Journal of Hepatology. 2006;45(4):484–8.Google Scholar
McCormack, L, Dutkowski, P, El-Badry, AM, Clavien, PA. Liver Transplantation Using Fatty Livers: Always Feasible? Journal of Hepatology. 2011;54(5):1055–62.Google Scholar
Op den Dries, S, Sutton, ME, Lisman, T, Porte, RJ. Protection of Bile Ducts in Liver Transplantation: Looking beyond Ischemia. Transplantation. 2011;92(4):373–9.Google Scholar
Fontes, P, Lopez, R, van der Plaats, A, Vodovotz, Y, Minervini, M, Scott, V, et al. Liver Preservation with Machine Perfusion and a Newly Developed Cell-free Oxygen Carrier Solution under Subnormothermic Conditions. Am J Transplant. 2015;15(2):381–94.Google Scholar
Orman, ES, Mayorga, ME, Wheeler, SB, Townsley, RM, Toro-Diaz, HH, Hayashi, PH, et al. Declining Liver Graft Quality Threatens the Future of Liver Transplantation in the United States. Liver Transpl. 2015;21(8):1040–50.Google Scholar
Orman, ES, ASt, Barritt, Wheeler, SB, Hayashi, PH. Declining Liver Utilization for Transplantation in the United States and the Impact of Donation after Cardiac Death. Liver Transpl. 2013;19(1):5968.Google Scholar
Weeder, PD, van Rijn, R, Porte, RJ. Machine Perfusion in Liver Transplantation as a Tool to Prevent Non-anastomotic Biliary Strictures: Rationale, Current Evidence and Future Directions. Journal of Hepatology. 2015;63(1):265–75.CrossRefGoogle ScholarPubMed
Foley, DP, Fernandez, LA, Leverson, G, Anderson, M, Mezrich, J, Sollinger, HW, et al. Biliary Complications after Liver Transplantation from Donation after Cardiac Death Donors: An Analysis of Risk Factors and Long-term Outcomes from a Single Center. Ann Surg. 2011;253(4):817–25.Google Scholar
Abt, P, Crawford, M, Desai, N, Markmann, J, Olthoff, K, Shaked, A. Liver Transplantation from Controlled Non-Heart-Beating Donors: An Increased Incidence of Biliary Complications. Transplantation. 2003;75(10):1659–63.CrossRefGoogle ScholarPubMed
Jay, CL, Lyuksemburg, V, Ladner, DP, Wang, E, Caicedo, JC, Holl, JL, et al. Ischemic Cholangiopathy after Controlled Donation after Cardiac Death Liver Transplantation: A Meta-analysis. Ann Surg. 2011;253(2):259–64.CrossRefGoogle ScholarPubMed
Schlegel, A, Dutkowski, P. Role of Hypothermic Machine Perfusion in Liver Transplantation. Transpl Int. 2015;28(6):677–89.CrossRefGoogle ScholarPubMed
Liu, Q, Nassar, A, Farias, K, Buccini, L, Baldwin, W, Mangino, M, et al. Sanguineous Normothermic Machine Perfusion Improves Hemodynamics and Biliary Epithelial Regeneration in Donation after Cardiac Death Porcine Livers. Liver Transpl. 2014;20(8):987–99.CrossRefGoogle ScholarPubMed
Ravikumar, R, Leuvenink, H, Friend, PJ. Normothermic Liver Preservation: A New Paradigm? Transpl Int. 2015;28(6):690–9.CrossRefGoogle ScholarPubMed
Slieker, JC, Farid, WR, van Eijck, CH, Lange, JF, van Bommel, J, Metselaar, HJ, et al. Significant Contribution of the Portal Vein to Blood Flow through the Common Bile Duct. Ann Surg. 2012;255(3):523–7.Google Scholar
Barrou, B, Billault, C, Nicolas-Robin, A. The Use of Extracorporeal Membranous Oxygenation in Donors after Cardiac Death. Curr Opin Organ Transplant. 2013;18(2):148–53.CrossRefGoogle ScholarPubMed
Karimian, N, Op den Dries, S, Porte, RJ. The Origin of Biliary Strictures after Liver Transplantation: Is It the Amount of Epithelial Injury or Insufficient Regeneration that Counts? Journal of Hepatology. 2013;58(6):1065–7.CrossRefGoogle ScholarPubMed
Boehnert, MU, Yeung, JC, Bazerbachi, F, Knaak, JM, Selzner, N, McGilvray, ID, et al. Normothermic Acellular ex Vivo Liver Perfusion Reduces Liver and Bile Duct Injury of Pig Livers Retrieved after Cardiac Death. Am J Transplant. 2013;13(6):1441–9.Google ScholarPubMed
Brunner, SM, Junger, H, Ruemmele, P, Schnitzbauer, AA, Doenecke, A, Kirchner, GI, et al. Bile Duct Damage after Cold Storage of Deceased Donor Livers Predicts Biliary Complications after Liver Transplantation. Journal of Hepatology. 2013;58(6):1133–9.Google Scholar
Hansen, T, Hollemann, D, Pitton, MB, Heise, M, Hoppe-Lotichius, M, Schuchmann, M, et al. Histological Examination and Evaluation of Donor Bile Ducts Received during Orthotopic Liver Transplantation–A Morphological Clue to Ischemic-type Biliary Lesion? Virchows Arch. 2012;461(1):41–8.Google Scholar
Op den Dries, S, Westerkamp, AC, Karimian, N, Gouw, AS, Bruinsma, BG, Markmann, JF, et al. Injury to Peribiliary Glands and Vascular Plexus before Liver Transplantation Predicts Formation of Non-anastomotic Biliary Strictures. Journal of Hepatology. 2014.CrossRefGoogle Scholar
Karimian, N, Westerkamp, AC, Porte, RJ. Biliary Complications after Orthotopic Liver Transplantation. Curr Opin Organ Transplant. 2014;19(3):209–16.Google Scholar
Karimian, N, Weeder, PD, Bomfati, F, Gouw, AS, Porte, RJ. Preservation Injury of the Distal Extrahepatic Bile Duct of Donor Livers Is Representative for Injury of the Intrahepatic Bile Ducts. Journal of Hepatology. 2015;63(1):284–7.Google Scholar
Clavien, PA, Harvey, PR, Strasberg, SM. Preservation and Reperfusion Injuries in Liver Allografts. An Overview and Synthesis of Current Studies. Transplantation. 1992;53(5):957–78.Google Scholar
Schon, MR, Kollmar, O, Wolf, S, Schrem, H, Matthes, M, Akkoc, N, et al. Liver Transplantation after Organ Preservation with Normothermic Extracorporeal Perfusion. Ann Surg. 2001;233(1):114–23.Google Scholar
Friend, PJ, Imber, C, St Peter, S, Lopez, I, Butler, AJ, Rees, MA. Normothermic Perfusion of the Isolated Liver. Transplantation Proceedings. 2001;33(7–8):3436–8.Google Scholar
Butler, AJ, Rees, MA, Wight, DG, Casey, ND, Alexander, G, White, DJ, et al. Successful Extracorporeal Porcine Liver Perfusion for 72 Hr. Transplantation. 2002;73(8):1212–8.Google Scholar
Imber, CJ, St Peter, SD, Lopez de Cenarruzabeitia, I, Pigott, D, James, T, Taylor, R, et al. Advantages of Normothermic Perfusion over Cold Storage in Liver Preservation. Transplantation. 2002;73(5):701–9.Google Scholar
Reddy, S, Greenwood, J, Maniakin, N, Bhattacharjya, S, Zilvetti, M, Brockmann, J, et al. Non-Heart-Beating Donor Porcine Livers: The Adverse Effect of Cooling. Liver Transpl. 2005;11(1):35–8.CrossRefGoogle ScholarPubMed
Boehnert, MU, Yeung, JC, Knaak, JM, Selzner, N, Selzner, M. Normothermic Acellular ex Vivo Liver Perfusion (NEVLP) Reduces Liver and Bile Duct in DCD Liver Grafts. Am J Transplant. 2013;13(12):3290.Google Scholar
Sutton, ME, op den Dries, S, Karimian, N, Weeder, PD, de Boer, MT, Wiersema-Buist, J, et al. Criteria for Viability Assessment of Discarded Human Donor Livers during ex Vivo Normothermic Machine Perfusion. PLoS One. 2014;9(11):e110642.Google Scholar
Guarrera, JV, Henry, SD, Samstein, B, Reznik, E, Musat, C, Lukose, TI, et al. Hypothermic Machine Preservation Facilitates Successful Transplantation of “Orphan” Extended Criteria Donor Livers. Am J Transplant. 2015;15(1):161–9.Google Scholar
Dutkowski, P, Furrer, K, Tian, Y, Graf, R, Clavien, PA. Novel Short-term Hypothermic Oxygenated Perfusion (HOPE) System Prevents Injury in Rat Liver Graft from Non-Heart Beating Donor. Ann Surg. 2006;244(6):968–76; discussion 76–7.Google Scholar
Schlegel, A, Graf, R, Clavien, PA, Dutkowski, P. Hypothermic Oxygenated Perfusion (HOPE) Protects from Biliary Injury in a Rodent Model of DCD Liver Transplantation. Journal of Hepatology. 2013;59(5):984–91.Google Scholar
Op den Dries, S, Sutton, ME, Karimian, N, de Boer, MT, Wiersema-Buist, J, Gouw, AS, et al. Hypothermic Oxygenated Machine Perfusion Prevents Arteriolonecrosis of the Peribiliary Plexus in Pig Livers Donated after Circulatory Death. PLoS One. 2014;9(2):e88521.Google Scholar
Berendsen, TA, Bruinsma, BG, Lee, J, D’Andrea, V, Liu, Q, Izamis, ML, et al. A Simplified Subnormothermic Machine Perfusion System Restores Ischemically Damaged Liver Grafts in a Rat Model of Orthotopic Liver Transplantation. Transplantation Research. 2012;1(1):6.CrossRefGoogle Scholar
Bruinsma, BG, Yeh, H, Ozer, S, Martins, PN, Farmer, A, Wu, W, et al. Subnormothermic Machine Perfusion for ex Vivo Preservation and Recovery of the Human Liver for Transplantation. Am J Transplant. 2014;14(6):1400–9.Google Scholar
Tolboom, H, Izamis, ML, Sharma, N, Milwid, JM, Uygun, B, Berthiaume, F, et al. Subnormothermic Machine Perfusion at Both 20 Degrees C and 30 Degrees C Recovers Ischemic Rat Livers for Successful Transplantation. J Surg Res. 2012;175(1):149–56.CrossRefGoogle Scholar
Knaak, JM, Spetzler, VN, Goldaracena, N, Boehnert, MU, Bazerbachi, F, Louis, KS, et al. Subnormothermic ex Vivo Liver Perfusion Reduces Endothelial Cell and Bile Duct Injury after Donation after Cardiac Death Pig Liver Transplantation. Liver Transpl. 2014;20(11):1296–305.Google Scholar
Routh, D, Naidu, S, Sharma, S, Ranjan, P, Godara, R. Changing Pattern of Donor Selection Criteria in Deceased Donor Liver Transplant: A Review of Literature. J Clin Exp Hepatol. 2013;3(4):337–46.Google Scholar
Harring, TR, O’Mahony, CA, Goss, JA. Extended Donors in Liver Transplantation. Clinics in Liver Disease. 2011;15(4):879900.Google Scholar
Nickkholgh, A, Weitz, J, Encke, J, Sauer, P, Mehrabi, A, Büchler, MW, et al. Utilization of Extended Donor Criteria in Liver Transplantation: A Comprehensive Review of the Literature. Nephrol Dial Transplant. 2007;22 Suppl 8:viii29viii36.Google Scholar
Busuttil, RW, Tanaka, K. The Utility of Marginal Donors in Liver Transplantation. Liver Transpl. 2003;9(7):651–63.Google Scholar
Alkofer, B, Samstein, B, Guarrera, JV, Kin, C, Jan, D, Bellemare, S, et al. Extended-donor Criteria Liver Allografts. Seminars in Liver Disease. 2006;26(3):221–33.Google Scholar
Feng, S, Goodrich, NP, Bragg-Gresham, JL, Dykstra, DM, Punch, JD, DebRoy, MA, et al. Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index. Am J Transplant. 2006;6(4):783–90.CrossRefGoogle ScholarPubMed
Nalesnik, MA, Woodle, ES, Dimaio, JM, Vasudev, B, Teperman, LW, Covington, S, et al. Donor-transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(6):1140–7.Google Scholar
Ison, MG, Nalesnik, MA. An Update on Donor-derived Disease Transmission in Organ Transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(6):1123–30.Google Scholar
Green, M, Covington, S, Taranto, S, Wolfe, C, Bell, W, Biggins, SW, et al. Donor-derived Transmission Events in 2013: A Report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee. Transplantation. 2015;99(2):282–7.Google Scholar
Reich, DJ, Mulligan, DC, Abt, PL, Pruett, TL, Abecassis, MM, D’Alessandro, A, et al. ASTS Recommended Practice Guidelines for Controlled Donation after Cardiac Death Organ Procurement and Transplantation. Am J Transplant. 2009;9(9):2004–11.Google Scholar
Todo, S, Demetris, AJ, Makowka, L, Teperman, L, Podesta, L, Shaver, T, et al. Primary Nonfunction of Hepatic Allografts with Preexisting Fatty Infiltration. Transplantation. 1989;47(5):903–5.Google Scholar
Kakizoe, S, Yanaga, K, Starzl, TE, Demetris, AJ. Frozen Section of Liver Biopsy for the Evaluation of Liver Allografts. Transplant Proc. 1990;22(2):416–7.Google Scholar
Zamboni, F, Franchello, A, David, E, Rocca, G, Ricchiuti, A, Lavezzo, B, et al. Effect of Macrovescicular Steatosis and Other Donor and Recipient Characteristics on the Outcome of Liver Transplantation. Clin Transplant. 2001;15(1):53–7.Google Scholar
Spitzer, AL, Lao, OB, Dick, AA, Bakthavatsalam, R, Halldorson, JB, Yeh, MM, et al. The Biopsied Donor Liver: Incorporating Macrosteatosis into High-risk Donor Assessment. Liver Transpl. 2010;16(7):874–84.Google Scholar
Sharkey, FE, Lytvak, I, Prihoda, TJ, Speeg, KV, Washburn, WK, Halff, GA. High-grade Microsteatosis and Delay in Hepatic Function after Orthotopic Liver Transplantation. Human Pathology. 2011;42(9):1337–42.Google Scholar
Fiorini, RN, Kirtz, J, Periyasamy, B, Evans, Z, Haines, JK, Cheng, G, et al. Development of an Unbiased Method for the Estimation of Liver Steatosis. Clin Transplant. 2004;18(6):700–6.Google Scholar
D’Alessandro, AM, Kalayoglu, M, Sollinger, HW, Hoffmann, RM, Reed, A, Knechtle, SJ, et al. The Predictive Value of Donor Liver Biopsies for the Development of Primary Nonfunction after Orthotopic Liver Transplantation. Transplantation. 1991;51(1):157–63.Google Scholar
McCormack, L, Petrowsky, H, Jochum, W, Mullhaupt, B, Weber, M, Clavien, PA. Use of Severely Steatotic Grafts in Liver Transplantation: A Matched Case-control Study. Ann Surg. 2007;246(6):940–6; discussion 68.Google Scholar
Angele, MK, Rentsch, M, Hartl, WH, Wittmann, B, Graeb, C, Jauch, KW, et al. Effect of Graft Steatosis on Liver Function and Organ Survival after Liver Transplantation. Am J Surg. 2008;195(2):214–20.Google Scholar
D’Alessandro, E, Calabrese, F, Gringeri, E, Valente, M. Frozen-section Diagnosis in Donor Livers: Error Rate Estimation of Steatosis Degree. Transplantation Proceedings. 2010;42(6):2226–8.Google Scholar
Fiorentino, M, Vasuri, F, Ravaioli, M, Ridolfi, L, Grigioni, WF, Pinna, AD, et al. Predictive Value of Frozen-section Analysis in the Histological Assessment of Steatosis before Liver Transplantation. Liver Transpl. 2009;15(12):1821–5.Google Scholar
Chen, CL, Cheng, YF, Yu, CY, Ou, HY, Tsang, LL, Huang, TL, et al. Living Donor Liver Transplantation: The Asian Perspective. Transplantation. 2014;97 Suppl 8:S3.Google Scholar
Markin, RS, Wisecarver, JL, Radio, SJ, Stratta, RJ, Langnas, AN, Hirst, K, et al. Frozen Section Evaluation of Donor Livers before Transplantation. Transplantation. 1993;56(6):1403–9.Google Scholar
Patwardhan, VR, Curry, MP. Reappraisal of the Hepatitis C Virus-positive Donor in Solid Organ Transplantation. Curr Opin Organ Transplant. 2015;20(3):267–75.Google Scholar
Ballarin, R, Cucchetti, A, Spaggiari, M, Montalti, R, Di Benedetto, F, Nadalin, S, et al. Long-term Follow-up and Outcome of Liver Transplantation from Anti-hepatitis C virus-positive Donors: A European Multicentric Case-control Study. Transplantation. 2011;91(11):1265–72.Google Scholar
Dodson, SF, Issa, S, Araya, V, Gayowski, T, Pinna, A, Eghtesad, B, et al. Infectivity of Hepatic Allografts with Antibodies to Hepatitis B Virus. Transplantation. 1997;64(11):1582–4.CrossRefGoogle ScholarPubMed
Avelino-Silva, VI, D’Albuquerque, LA, Bonazzi, PR, Song, AT, Miraglia, JL, De Brito Neves, A, et al. Liver Transplant from Anti-HBc-positive, HBsAg-negative Donor into HBsAg-negative Recipient: Is It Safe? A Systematic Review of the Literature. Clin Transplant. 2010;24(6):735–46.Google Scholar
Adams, D, Lacroix, C, Antonini, T, Lozeron, P, Denier, C, Kreib, AM, et al. Symptomatic and Proven de Novo Amyloid Polyneuropathy in Familial Amyloid Polyneuropathy Domino Liver Recipients. Amyloid. 2011;18 Suppl 1:169–72.Google Scholar
Aziz, S, Callen, PW, Vincenti, F, Hirose, R. Rapidly Developing Nephrocalcinosis in a Patient with End-stage Liver Disease Who Received a Domino Liver Transplant from a Patient with Known Congenital Oxalosis. J Ultrasound Med. 2005;24(10):1449–52.Google Scholar
Lee, SM, Speeg, KV, Pollack, MS, Sharkey, FE. Progression of Morphological Changes after Transplantation of a Liver with Heterozygous Alpha-1 Antitrypsin Deficiency. Human Pathology. 2011.Google Scholar
Tanaka, K, Kiuchi, T. Living-donor Liver Transplantation in the New Decade: Perspective from the Twentieth to the Twenty-first Century. J Hepatobiliary Pancreat Surg. 2002;9(2):218–22.Google Scholar
Song, GW, Lee, SG. Living Donor Liver Transplantation. Curr Opin Organ Transplant. 2014;19(3):217–22.Google Scholar
Cheah, YL, Simpson, MA, Pomposelli, JJ, Pomfret, EA. Incidence of Death and Potentially Life-threatening Near-miss Events in Living Donor Hepatic Lobectomy: A World-wide Survey. Liver Transpl. 2013;19(5):499506.Google Scholar
Nadalin, S, Malago, M, Valentin-Gamazo, C, Testa, G, Baba, HA, Liu, C, et al. Preoperative Donor Liver Biopsy for Adult Living Donor Liver Transplantation: Risks and Benefits. Liver Transpl. 2005;11(8):980–6.Google Scholar
Tran, TT, Changsri, C, Shackleton, CR, Poordad, FF, Nissen, NN, Colquhoun, S, et al. Living Donor Liver Transplantation: Histological Abnormalities Found on Liver Biopsies of Apparently Healthy Potential Donors. J Gastroenterol Hepatol. 2006;21(2):381–3.Google Scholar
Ryan, CK, Johnson, LA, Germin, BI, Marcos, A. One Hundred Consecutive Hepatic Biopsies in the Workup of Living Donors for Right Lobe Liver Transplantation. Liver Transpl. 2002;8(12):1114–22.Google Scholar
Trotter, JF, Wachs, M, Everson, GT, Kam, I. Adult-to-Adult Transplantation of the Right Hepatic Lobe from a Living Donor. The New England Journal of Medicine. 2002;346(14):1074–82.Google Scholar
Simpson, MA, Pomfret, EA. Checking the Harness: Safety for Living Liver Donors. Liver Transpl. 2012;18 Suppl 2:S159.Google Scholar
Minervini, MI, Ruppert, K, Fontes, P, Volpes, R, Vizzini, G, de Vera, ME, et al. Liver Biopsy Findings from Healthy Potential Living Liver Donors: Reasons for Disqualification, Silent Diseases and Correlation with Liver Injury Tests. Journal of Hepatology. 2009;50(3):501–10.Google Scholar
Lee, JY, Kim, KM, Lee, SG, Yu, E, Lim, YS, Lee, HC, et al. Prevalence and Risk Factors of Non-alcoholic Fatty Liver Disease in Potential Living Liver Donors in Korea: A Review of 589 Consecutive Liver Biopsies in a Single Center. Journal of Hepatology. 2007;47(2):239–44.Google Scholar
Rinella, ME, Alonso, E, Rao, S, Whitington, P, Fryer, J, Abecassis, M, et al. Body Mass Index as a Predictor of Hepatic Steatosis in Living Liver Donors. Liver Transpl. 2001;7(5):409–14.Google Scholar
Fan, ST, Lo, CM, Liu, CL, Yong, BH, Chan, JK, Ng, IO. Safety of Donors in Live Donor Liver Transplantation Using Right Lobe Grafts. Archives of Surgery. 2000;135(3):336–40.Google Scholar
Dorwal, P, Gautam, D, Sharma, D, Singh, DR, Raina, V. Donor Biopsy in Living Donor Liver Transplantation: Is It Still Relevant in a Developing Country? Malays J Pathol. 2015;37(1):3943.Google Scholar
Starzl, TE. History of Liver and Other Splanchnic Organ Transplantation. In: Busuttil, R, Klintmalm, G, editors. Transplantation of the Liver. Philadelphia: W.B. Saunders Company; 1996. p. 322.Google Scholar
Rockey, DC, Caldwell, SH, Goodman, ZD, Nelson, RC, Smith, AD. Liver Biopsy. Hepatology. 2009;49(3):1017–44.Google Scholar
Pathology, BWGoLA. Importance of Liver Biopsy Findings in Immunosuppression Management: Biopsy Monitoring and Working Criteria for Patients with Operational Tolerance. Liver Transpl. 2012;18(10):1154–70.Google Scholar
Bellizzi, AM, LeGallo, RD, Boyd, JC, Iezzoni, JC. Hepatocyte Cytokeratin 7 Expression in Chronic Allograft Rejection. Am J Clin Pathol. 2011;135(2):238–44.Google Scholar
Demetris, AJ, Jaffe, R, Starzl, TE. A Review of Adult and Pediatric Post-transplant Liver Pathology. Pathol Annu. 1987;22(Pt 2):347–86.Google Scholar
Sieders, E, Peeters, PM, TenVergert, EM, de Jong, KP, Porte, RJ, Zwaveling, JH, et al. Graft Loss after Pediatric Liver Transplantation. Annals of Surgery. 2002;235(1):125–32.Google Scholar
Kashyap, R, Jain, A, Reyes, J, Demetris, AJ, Elmagd, KA, Dodson, SF, et al. Causes of Retransplantation after Primary Liver Transplantation in 4000 Consecutive Patients: 2 to 19 Years Follow-up. Transplantation Proceedings. 2001;33(1–2):1486–7.Google Scholar
Jain, A, Reyes, J, Kashyap, R, Dodson, SF, Demetris, AJ, Ruppert, K, et al. Long-term Survival after Liver Transplantation in 4,000 Consecutive Patients at a Single Center. Ann Surg. 2000;232(4):490500.Google Scholar
Rabkin, JM, de La Melena, V, Orloff, SL, Corless, CL, Rosen, HR, Olyaei, AJ. Late Mortality after Orthotopic Liver Transplantation. Am J Surg. 2001;181(5):475–9.Google Scholar
Kitchens, WH, Yeh, H, Markmann, JF. Hepatic Retransplant: What Have We Learned? Clin Liver Dis. 2014;18(3):731–51.Google Scholar
Jain, A, Demetris, AJ, Kashyap, R, Blakomer, K, Ruppert, K, Khan, A, et al. Does Tacrolimus Offer Virtual Freedom from Chronic Rejection after Primary Liver Transplantation? Risk and Prognostic Factors in 1,048 Liver Transplantations with a Mean Follow-up of 6 Years. Liver Transpl. 2001;7(7):623–30.Google Scholar
McCashland, T, Watt, K, Lyden, E, Adams, L, Charlton, M, Smith, AD, et al. Retransplantation for Hepatitis C: Results of a U.S. Multicenter Retransplant Study. Liver Transpl. 2007;13(9):1246–53.Google Scholar
Kim, KR, Ko, GY, Sung, KB, Yoon, HK, Shin, JH, Song, HY, et al. Transjugular Liver Biopsy in Patients with Living Donor Liver Transplantation: Comparison with Percutaneous Biopsy. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2008;14(7):971–9.Google Scholar
Astarcioglu, I, Cursio, R, Reynes, M, Gugenheim, J. Increased Risk of Antibody-mediated Rejection of Reduced-size Liver Allografts. J Surg Res. 1999;87(2):258–62.Google Scholar
Demetris, AJ, Kelly, DM, Eghtesad, B, Fontes, P, Wallis Marsh, J, Tom, K, et al. Pathophysiologic Observations and Histopathologic Recognition of the Portal Hyperperfusion or Small-for-Size Syndrome. Am J Surg Pathol. 2006;30(8):986–93.Google Scholar
Peralta, C, Jiménez-Castro, MB, Gracia-Sancho, J. Hepatic Ischemia and Reperfusion Injury: Effects on the Liver Sinusoidal Milieu. Journal of Hepatology. 2013;59(5):1094–106.Google Scholar
Zhai, Y, Petrowsky, H, Hong, JC, Busuttil, RW, Kupiec-Weglinski, JW. Ischaemia-Reperfusion Injury in Liver Transplantation–From Bench to Bedside. Nat Rev Gastroenterol Hepatol. 2013;10(2):7989.Google Scholar
Hong, JC, Yersiz, H, Kositamongkol, P, Xia, VW, Kaldas, FM, Petrowsky, H, et al. Liver Transplantation Using Organ Donation after Cardiac Death: A Clinical Predictive Index for Graft Failure-free Survival. Arch Surg. 2011;146(9):1017–23.Google Scholar
de Vera, ME, Lopez-Solis, R, Dvorchik, I, Campos, S, Morris, W, Demetris, AJ, et al. Liver Transplantation Using Donation after Cardiac Death Donors: Long-term Follow-up from a Single Center. Am J Transplant. 2009;9(4):773–81.Google Scholar
Taner, CB, Bulatao, IG, Willingham, DL, Perry, DK, Sibulesky, L, Pungpapong, S, et al. Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation after Cardiac Death Donors. Liver Transpl. 2012;18(1):100–11.Google Scholar
Kakizoe, S, Yanaga, K, Starzl, TE, Demetris, AJ. Evaluation of Protocol before Transplantation and after Reperfusion Biopsies from Human Orthotopic Liver Allografts: Considerations of Preservation and Early Immunological Injury. Hepatology. 1990;11(6):932–41.Google Scholar
Ludwig, J, Batts, KP, MacCarty, RL. Ischemic Cholangitis in Hepatic Allografts. Mayo Clinic Proceedings. 1992;67(6):519–26.Google Scholar
Cameron, AM, Busuttil, RW. Ischemic Cholangiopathy after Liver Transplantation. Hepatobiliary Pancreat Dis Int. 2005;4(4):495501.Google Scholar
Kocbiyik, A, Demirhan, B, Sevmis, S, Budakoglu, I, Karakayali, H, Haberal, M. Role of Postreperfusion Subcapsular Wedge Biopsies in Predicting Initially Poor Graft Function after Liver Transplantation. Transplantation Proceedings. 2009;41(7):2747–8.Google Scholar
Ali, JM, Davies, SE, Brais, RJ, Randle, LV, Klinck, JR, Allison, ME, et al. Analysis of Ischemia/Reperfusion Injury in Time-zero Biopsies Predicts Liver Allograft Outcomes. Liver Transpl. 2015;21(4):487–99.Google Scholar
Shahbazi, N, Haeri, H, Nasiri Toosi, M, Jafarian, A, Shahsiah, R, Talebian Moghadam, M, et al. Correlation of Histopathologic Findings of Non-graft Threatening Preservation/Reperfusion Injury in Time-zero Liver Needle Biopsies With Short-term Post-transplantation Laboratory Alterations. Hepat Mon. 2015;15(6):e30008.Google Scholar
Kukan, M, Haddad, PS. Role of Hepatocytes and Bile Duct Cells in Preservation-Reperfusion Injury of Liver Grafts. Liver Transpl. 2001;7(5):381400.Google Scholar
Lunz, J, Ruppert, KM, Cajaiba, MM, Isse, K, Bentlejewski, CA, Minervini, M, et al. Re-examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring? American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2012;12(1):171–82.Google Scholar
Dahm, F, Georgiev, P, Clavien, PA. Small-for-Size Syndrome after Partial Liver Transplantation: Definition, Mechanisms of Disease and Clinical Implications. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2005;5(11):2605–10.Google Scholar
Chan, SC, Lo, CM, Fan, ST. Simplifying Living Donor Liver Transplantation. Hepatobiliary & Pancreatic Diseases International: HBPD INT. 2010;9(1):914.Google Scholar
Chan, SC, Lo, CM, Ng, KK, Ng, IO, Yong, BH, Fan, ST. Portal Inflow and Pressure Changes in Right Liver Living Donor Liver Transplantation Including the Middle Hepatic Vein. Liver Transpl. 2011;17(2):115–21.Google Scholar
Man, K, Fan, ST, Lo, CM, Liu, CL, Fung, PC, Liang, TB, et al. Graft Injury in Relation to Graft Size in Right Lobe Live Donor Liver Transplantation: A Study of Hepatic Sinusoidal Injury in Correlation with Portal Hemodynamics and Intragraft Gene Expression. Ann Surg. 2003;237(2):256–64.Google Scholar
Lautt, WW. Mechanism and Role of Intrinsic Regulation of Hepatic Arterial Blood Flow: Hepatic Arterial Buffer Response. Am J Physiol. 1985;249(5 Pt 1):G54956.Google Scholar
Eipel, C, Abshagen, K, Vollmar, B. Regulation of Hepatic Blood Flow: The Hepatic Arterial Buffer Response Revisited. World J Gastroenterol. 2010;16(48):6046–57.Google Scholar
Kelly, DM, Zhu, X, Shiba, H, Irefin, S, Trenti, L, Cocieru, A, et al. Adenosine Restores the Hepatic Artery Buffer Response and Improves Survival in a Porcine Model of Small-for-Size Syndrome. Liver Transpl. 2009;15(11):1448–57.Google Scholar
Botha, JF, Langnas, AN, Campos, BD, Grant, WJ, Freise, CE, Ascher, NL, et al. Left Lobe Adult-to-Adult Living Donor Liver Transplantation: Small Grafts and Hemiportocaval Shunts in the Prevention of Small-for-Size Syndrome. Liver Transpl. 2010;16(5):649–57.Google Scholar
Michalopoulos, GK. Principles of Liver Regeneration and Growth Homeostasis. Compr Physiol. 2013;3(1):485513.Google Scholar
Starzl, TE, Fung, JJ. Themes of Liver Transplantation. Hepatology. 2010;51(6):1869–84.Google Scholar
Hessheimer, AJ, Fondevila, C, Taura, P, Munoz, J, Sanchez, O, Fuster, J, et al. Decompression of the Portal Bed and Twice-baseline Portal Inflow are Necessary for the Functional Recovery of a “Small-for-Size” Graft. Annals of Surgery. 2011;253(6):1201–10.Google Scholar
Fondevila, C, Hessheimer, AJ, Taura, P, Sanchez, O, Calatayud, D, de Riva, N, et al. Portal Hyperperfusion: Mechanism of Injury and Stimulus for Regeneration in Porcine Small-for-Size Transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2010;16(3):364–74.Google Scholar
Kelly, DM, Demetris, AJ, Fung, JJ, Marcos, A, Zhu, Y, Subbotin, V, et al. Porcine Partial Liver Transplantation: A Novel Model of the “Small-for-Size” Liver Graft. Liver Transpl. 2004;10(2):253–63.Google Scholar
Yagi, Y, Gilbertson, JR. Digital Imaging in Pathology: The Case for Standardization. Journal of Telemedicine and Telecare. 2005;11(3):109–16.Google Scholar
Fukuhara, T, Umeda, K, Toshima, T, Takeishi, K, Morita, K, Nagata, S, et al. Congestion of the Donor Remnant Right Liver after Extended Left Lobe Donation. Transplant International: Official Journal of the European Society for Organ Transplantation. 2009;22(8):837–44.Google Scholar
Man, K, Lo, CM, Ng, IO, Wong, YC, Qin, LF, Fan, ST, et al. Liver Transplantation in Rats Using Small-for-Size Grafts: A Study of Hemodynamic and Morphological Changes. Arch Surg. 2001;136(3):280–5.Google Scholar
Asakura, T, Ohkohchi, N, Orii, T, Koyamada, N, Tsukamoto, S, Sato, M, et al. Portal Vein Pressure Is the Key for Successful Liver Transplantation of an Extremely Small Graft in the Pig Model. Transpl Int. 2003;16(6):376–82.Google Scholar
Ayata, G, Pomfret, E, Pomposelli, JJ, Gordon, FD, Lewis, WD, Jenkins, RL, et al. Adult-to-Adult Live Donor Liver Transplantation: A Short-term Clinicopathologic Study. Hum Pathol. 2001;32(8):814–22.Google Scholar
Pantanowitz, L, Pomfret, EA, Pomposelli, JJ, Lewis, WD, Gordon, FD, Jenkins, RL, et al. Pathologic Analysis of Right-lobe Graft Failure in Adult-to-Adult Live Donor Liver Transplantation. Int J Surg Pathol. 2003;11(4):283–94.Google Scholar
Bekker, J, Ploem, S, de Jong, KP. Early Hepatic Artery Thrombosis after Liver Transplantation: A Systematic Review of the Incidence, Outcome and Risk Factors. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009;9(4):746–57.Google Scholar
Gunsar, F, Rolando, N, Pastacaldi, S, Patch, D, Raimondo, ML, Davidson, B, et al. Late Hepatic Artery Thrombosis after Orthotopic Liver Transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2003;9(6):605–11.Google Scholar
Backman, L, Gibbs, J, Levy, M, McMillan, R, Holman, M, Husberg, B, et al. Causes of Late Graft Loss after Liver Transplantation. Transplantation. 1993;55(5):1078–82.Google Scholar
Demetris, AJ, Qian, SG, Sun, H, Fung, JJ. Liver Allograft Rejection: An Overview of Morphologic Findings. The American Journal of Surgical Pathology. 1990;14(Suppl 1):4963.Google Scholar
Demetris, A, Kakizoe, S, S. O. Pathology of Liver Transplantation. In: Williams, JW, editor. Hepatic Transplantation. Philadelphia: WB Saunders; 1990. p. 61111.Google Scholar
Liu, TC, Nguyen, TT, Torbenson, MS. Concurrent Increase in Mitosis and Apoptosis: A Histological Pattern of Hepatic Arterial Flow Abnormalities in Post-transplant Liver Biopsies. Mod Pathol. 2012;25(12):1594–8.Google Scholar
Ponziani, FR, Zocco, MA, Campanale, C, Rinninella, E, Tortora, A, Di Maurizio, L, et al. Portal Vein Thrombosis: Insight into Physiopathology, Diagnosis, and Treatment. World Journal of Gastroenterology: WJG. 2010;16(2):143–55.Google Scholar
Alvarez, F. Portal Vein Complications after Pediatric Liver Transplantation. Curr Gastroenterol Rep. 2012;14(3):270–4.Google Scholar
Kuang, AA, Renz, JF, Ferrell, LD, Ring, EJ, Rosenthal, P, Lim, RC, et al. Failure Patterns of Cryopreserved Vein Grafts in Liver Transplantation. Transplantation. 1996;62(6):742–7.CrossRefGoogle ScholarPubMed
Zahmatkeshan, M, Geramizadeh, B, Eshraghian, A, Nikeghbalian, S, Bahador, A, Salahi, H, et al. De Novo Fatty Liver due to Vascular Complications after Liver Transplantation. Transplantation Proceedings. 2011;43(2):615–7.Google Scholar
Zhang, S, Dong, Z, Zhang, M, Xia, Q, Liu, D, Zhang, JJ. Right Lobe Living-donor Liver Transplantation with or without Middle Hepatic Vein: A Meta-analysis. Transplantation Proceedings. 2011;43(10):3773–9.Google Scholar
Klintmalm, G, Busuttil, R. Transplantation of the Liver. Second ed. Klintmalm, G, Busuttil, R, editors. Philadelphia: Elsevier Saunders; 2005. 1485 p.Google Scholar
Sebagh, M, Debette, M, Samuel, D, Emile, JF, Falissard, B, Cailliez, V, et al. “Silent” Presentation of Veno-occlusive Disease after Liver Transplantation as Part of the Process of Cellular Rejection with Endothelial Predilection. Hepatology. 1999;30(5):1144–50.CrossRefGoogle ScholarPubMed
Pascher, A, Neuhaus, P. Bile Duct Complications after Liver Transplantation. Transpl Int. 2005;18(6):627–42.Google Scholar
Ghobrial, RM, Busuttil, RW. Challenges of Adult Living-donor Liver Transplantation. J Hepatobiliary Pancreat Surg. 2006;13(2):139–45.Google Scholar
Akamatsu, N, Sugawara, Y, Hashimoto, D. Biliary Reconstruction, Its Complications and Management of Biliary Complications after Adult Liver Transplantation: A Systematic Review of the Incidence, Risk Factors and Outcome. Transplant International: Official Journal of the European Society for Organ Transplantation. 2011;24(4):379–92.Google Scholar
Kochhar, G, Parungao, JM, Hanouneh, IA, Parsi, MA. Biliary Complications Following Liver Transplantation. World J Gastroenterol. 2013;19(19):2841–6.Google Scholar
Demetris, AJ, Murase, N, Nakamura, K, Iwaki, Y, Yagihashi, A, Valdivia, L, et al. Immunopathology of Antibodies as Effectors of Orthotopic Liver Allograft Rejection. Seminars in Liver Disease. 1992;12(1):51–9.Google Scholar
Demetris, AJ, Jaffe, R, Tzakis, A, Ramsey, G, Todo, S, Belle, S, et al. Antibody-mediated Rejection of Human Orthotopic Liver Allografts. A Study of Liver Transplantation across ABO Blood Group Barriers. American Journal of Pathology. 1988;132(3):489502.Google Scholar
Demetris, AJ, Lunz, JG 3rd, Specht, S, Nozaki, I. Biliary Wound Healing, Ductular Reactions, and IL-6/gp130 Signaling in the Development of Liver Disease. World J Gastroenterol. 2006;12(22):3512–22.Google Scholar
Verdonk, RC, Buis, CI, Porte, RJ, van der Jagt, EJ, Limburg, AJ, van den Berg, AP, et al. Anastomotic Biliary Strictures after Liver Transplantation: Causes and Consequences. Liver Transpl. 2006;12(5):726–35.Google Scholar
Verdonk, RC, Buis, CI, Porte, RJ, Haagsma, EB. Biliary Complications after Liver Transplantation: A Review. Scand J Gastroenterol Suppl. 2006(243):89101.Google Scholar
Verdonk, RC, Buis, CI, van der Jagt, EJ, Gouw, AS, Limburg, AJ, Slooff, MJ, et al. Nonanastomotic Biliary Strictures after Liver Transplantation, Part 2: Management, Outcome, and Risk Factors for Disease Progression. Liver Transpl. 2007;13(5):725–32.Google Scholar
Buis, CI, Verdonk, RC, Van der Jagt, EJ, van der Hilst, CS, Slooff, MJ, Haagsma, EB, et al. Nonanastomotic Biliary Strictures after Liver Transplantation, Part 1: Radiological Features and Risk Factors for Early vs. Late Presentation. Liver Transpl. 2007;13(5):708–18.Google Scholar
Song, GW, Lee, SG, Hwang, S, Kim, KH, Ahn, CS, Moon, DB, et al. Biliary Stricture is the Only Concern in ABO-incompatible Adult Living Donor Liver Transplantation in the Rituximab Era. Journal of Hepatology. 2014;61(3):575–82.Google Scholar
Foley, DP, Fernandez, LA, Leverson, G, Chin, LT, Krieger, N, Cooper, JT, et al. Donation after Cardiac Death: The University of Wisconsin Experience with Liver Transplantation. Ann Surg. 2005;242(5):724–31.Google Scholar
Demetris, A, Crawford, J, Nalesnik, M, Randhawa, P, Wu, T, Minervini, M. Transplantation Pathology of the Liver. In: Odze, R, Goldblum, J, Crawford, JM, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Philadelphia: WB Saunders; 2004. p. 909–66.Google Scholar
Pirenne, J, Aerts, R, Yoong, K, Gunson, B, Koshiba, T, Fourneau, I, et al. Liver Transplantation for Polycystic Liver Disease. Liver Transpl. 2001;7(3):238–45.Google Scholar
Minor, T, Hachenberg, A, Tolba, R, Pauleit, D, Akbar, S. Fibrinolytic Preflush upon Liver Retrieval from Non-Heart Beating Donors to Enhance Postpreservation Viability and Energetic Recovery upon Reperfusion. Transplantation. 2001;71(12):1792–6.CrossRefGoogle ScholarPubMed
Demetris, AJ, Fontes, P, Lunz, JG 3rd, Specht, S, Murase, N, Marcos, A. Wound Healing in the Biliary Tree of Liver Allografts. Cell Transplant. 2006;15 Suppl 1:S5765.Google Scholar
Demetris, AJ, Nakamura, K, Yagihashi, A, Iwaki, Y, Takaya, S, Hartman, GG, et al. A Clinicopathological Study of Human Liver Allograft Recipients Harboring Preformed IgG Lymphocytotoxic Antibodies. Hepatology. 1992;16(3):671–81.Google Scholar
Sanchez-Urdazpal, L, Batts, KP, Gores, GJ, Moore, SB, Sterioff, S, Wiesner, RH, et al. Increased Bile Duct Complications in Liver Transplantation across the ABO Barrier. Ann Surg. 1993;218(2):152–8.CrossRefGoogle ScholarPubMed
Jorgensen, JE, Waljee, AK, Volk, ML, Sonnenday, CJ, Elta, GH, Al-Hawary, MM, et al. Is MRCP Equivalent to ERCP for Diagnosing Biliary Obstruction in Orthotopic Liver Transplant Recipients? A Meta-analysis. Gastrointest Endosc. 2011;73(5):955–62.Google Scholar
Boraschi, P, Donati, F. Postoperative Biliary Adverse Events Following Orthotopic Liver Transplantation: Assessment with Magnetic Resonance Cholangiography. World J Gastroenterol. 2014;20(32):11080–94.Google Scholar
Girometti, R, Como, G, Bazzocchi, M, Zuiani, C. Post-operative Imaging in Liver Transplantation: State-of-the-Art and Future Perspectives. World J Gastroenterol. 2014;20(20):6180–200.Google Scholar
Hartshorne, N, Hartman, G, Markin, RS, Demetris, AJ, Ferrell, L. Bile Duct Hemorrhage: A Biopsy Finding after Cholangiography or Biliary Tree Manipulation. Liver. 1992;12(3):137–9.Google Scholar
Nagral, A, Ben-Ari, Z, Dhillon, AP, Burroughs, AK. Eosinophils in Acute Cellular Rejection in Liver Allografts. Liver Transpl Surg. 1998;4(5):355–62.Google Scholar
O’Leary, JG, Michelle Shiller, S, Bellamy, C, Nalesnik, MA, Kaneku, H, Jennings, LW, et al. Acute Liver Allograft Antibody-mediated Rejection: An Inter-institutional Study of Significant Histopathological Features. Liver Transpl. 2014;20(10):1244–55.Google ScholarPubMed
Lunz, JG 3rd, Contrucci, S, Ruppert, K, Murase, N, Fung, JJ, Starzl, TE, et al. Replicative Senescence of Biliary Epithelial Cells Precedes Bile Duct Loss in Chronic Liver Allograft Rejection: Increased Expression of p21(WAF1/Cip1) as a Disease Marker and the Influence of Immunosuppressive Drugs. Am J Pathol. 2001;158(4):1379–90.Google Scholar
Demetris, AJ. Distinguishing between Recurrent Primary Sclerosing Cholangitis and Chronic Rejection. Liver Transpl. 2006;12(11 Suppl 2):S6872.Google Scholar
Demetris, AJ, Crawford, JM, Isse, K, Minervini, MI, Nalesnik, MA, Rubin, E, et al. Pathology of Liver and Hematopoietic Stem Cell Transplantation. In: Odze, RD, Goldblum, JR, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas 3rd ed. Philadelphia, PA: Elsevier/Saunders; 2015. p. 1408–61.Google Scholar
Clendenon, JN, Aranda-Michel, J, Krishna, M, Taner, CB, Willingham, DL. Recurrent Liver Failure Caused by IgG4 Associated Cholangitis. Ann Hepatol. 2011;10(4):562–4.Google Scholar
Demetris, AJ, Eghtesad, B, Marcos, A, Ruppert, K, Nalesnik, MA, Randhawa, P, et al. Recurrent Hepatitis C in Liver Allografts: Prospective Assessment of Diagnostic Accuracy, Identification of Pitfalls, and Observations about Pathogenesis. Am J Surg Pathol. 2004;28(5):658–69.Google Scholar
O’Leary, JG, Kaneku, H, Demetris, AJ, Marr, JD, Shiller, SM, Susskind, BM, et al. Antibody-mediated Rejection as a Contributor to Previously Unexplained Early Liver Allograft Loss. Liver Transpl. 2014;20(2):218–27.Google Scholar
Kozlowski, T, Andreoni, K, Schmitz, J, Hayashi, PH, Nickeleit, V. Sinusoidal C4d Deposits in Liver Allografts Indicate an Antibody-mediated Response: Diagnostic Considerations in the Evaluation of Liver Allografts. Liver Transpl. 2012;18(6):641–58.Google Scholar
Gelson, W, Hoare, M, Dawwas, MF, Vowler, S, Gibbs, P, Alexander, G. The Pattern of Late Mortality in Liver Transplant Recipients in the United Kingdom. Transplantation. 2011;91(11):1240–4.Google Scholar
Duffy, JP, Kao, K, Ko, CY, Farmer, DG, McDiarmid, SV, Hong, JC, et al. Long-term Patient Outcome and Quality of Life after Liver Transplantation: Analysis of 20-year Survivors. Ann Surg. 2010;252(4):652–61.Google Scholar
O’Leary, JG, Demetris, AJ, Friedman, LS, Gebel, HM, Halloran, PF, Kirk, AD, et al. The Role of Donor-specific HLA Alloantibodies in Liver Transplantation. Am J Transplant. 2014;14(4):779–87.Google Scholar
Salah, A, Fujimoto, M, Yoshizawa, A, Yurugi, K, Miyagawa-Hayashino, A, Sumiyoshi, S, et al. Application of Complement Component 4d Immunohistochemistry to ABO-compatible and ABO-incompatible Liver Transplantation. Liver Transpl. 2014;20(2):200–9.Google Scholar
Rose, ML, West, LJ. Accommodation: Does It Apply to Human Leukocyte Antigens? Transplantation. 2012;93(3):244–6.Google Scholar
Raut, V, Uemoto, S. Management of ABO-incompatible Living-donor Liver Transplantation: Past and Present Trends. Surg Today. 2011;41(3):317–22.CrossRefGoogle ScholarPubMed
Haga, H, Egawa, H, Shirase, T, Miyagawa, A, Sakurai, T, Minamiguchi, S, et al. Periportal Edema and Necrosis as Diagnostic Histological Features of Early Humoral Rejection in ABO-incompatible Liver Transplantation. Liver Transpl. 2004;10(1):1627.Google Scholar
Ruiz, R, Tomiyama, K, Campsen, J, Goldstein, RM, Levy, MF, McKenna, GJ, et al. Implications of a Positive Crossmatch in Liver Transplantation: A 20-year Review. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011.Google Scholar
Al-Sibae, MR, Koffron, AJ, Raofi, V. Does a Positive Pretransplant Crossmatch Affect Long-term Outcome in Liver Transplantation? Transplantation. 2011;91(3):261–2.Google Scholar
Chan, KM, Lee, CS, Wu, TJ, Lee, CF, Chen, TC, Lee, WC. Clinical Perspective of Acute Humoral Rejection after Blood Type-compatible Liver Transplantation. Transplantation. 2011;91(5):e2930.CrossRefGoogle ScholarPubMed
O’Leary, J, Kaneku, H, Banuelos, N, Jennings, L, Klintmalm, G, Terasaki, P. Impact of IgG3 Subclass and C1q-fixing Donor Specific Antibodies on Rejection and Survival in Liver Transplantation. American Journal of Transplantation. 2015;(in press).Google Scholar
O’Leary, JG, Kaneku, H, Jennings, L, Susskind, BM, Terasaki, PI, Klintmalm, GB. Donor-specific Slloantibodies Are Associated with Fibrosis Progression after Liver Transplantation in Hepatitis C Virus-infected Patients. Liver Transpl. 2014;20(6):655–63.Google Scholar
Castillo-Rama, M, Castro, MJ, Bernardo, I, Meneu-Diaz, JC, Elola-Olaso, AM, Calleja-Antolin, SM, et al. Preformed Antibodies Detected by Cytotoxic Assay or Multibead Array Decrease Liver Allograft Survival: Role of Human Leukocyte Antigen Compatibility. Liver Transpl. 2008;14(4):554–62.Google Scholar
O’Leary, JG, Klintmalm, GB. Impact of Donor-specific Antibodies on Results of Liver Transplantation. Curr Opin Organ Transplant. 2013;18(3):279–84.Google Scholar
Taner, T, Gandhi, MJ, Sanderson, SO, Poterucha, CR, De Goey, SR, Stegall, MD, et al. Prevalence, Course and Impact of HLA Donor-specific Antibodies in Liver Transplantation in the First Year. Am J Transplant. 2012;12(6):1504–10.Google Scholar
Manez, R, Kelly, RH, Kobayashi, M, Takaya, S, Bronsther, O, Kramer, D, et al. Immunoglobulin G Lymphocytotoxic Antibodies in Clinical Liver Transplantation: Studies Toward Further Defining Their Significance. Hepatology. 1995;21(5):1345–52.Google Scholar
Doyle, HR, Marino, IR, Morelli, F, Doria, C, Aldrighetti, L, McMichael, J, et al. Assessing Risk in Liver Transplantation. Special Reference to the Significance of a Positive Cytotoxic Crossmatch. Ann Surg. 1996;224(2):168–77.Google Scholar
Kozlowski, T, Rubinas, T, Nickeleit, V, Woosley, J, Schmitz, J, Collins, D, et al. Liver Allograft Antibody-mediated Rejection with Demonstration of Sinusoidal C4d Staining and Circulating Donor-specific Antibodies. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(4):357–68.Google Scholar
Hubscher, SG. Antibody-mediated Rejection in the Liver Allograft. Curr Opin Organ Transplant. 2012;17(3):280–6.Google Scholar
Demetris, AJ, Bellamy, C, Hubscher, SG, O’Leary, J, Randhawa, PS, Feng, S, et al. 2016 Comprehensive Update of the BANFF Working Group on Liver Allograft Pathology: Introduction of Antibody-mediated Rejection. Am J Transplant. 2016.Google Scholar
Haga, H, Egawa, H, Fujimoto, Y, Ueda, M, Miyagawa-Hayashino, A, Sakurai, T, et al. Acute Humoral Rejection and C4d Immunostaining in ABO Blood Type-incompatible Liver Transplantation. Liver Transpl. 2006;12(3):457–64.Google Scholar
Egawa, H, Uemoto, S, Inomata, Y, Shapiro, AM, Asonuma, K, Kiuchi, T, et al. Biliary Complications in Pediatric Living Related Liver Transplantation. Surgery. 1998;124(5):901–10.Google Scholar
Sebagh, M, Farges, O, Kalil, A, Samuel, D, Bismuth, H, Reynes, M. Sclerosing Cholangitis Following Human Orthotopic Liver Transplantation. The American Journal of Surgical Pathology. 1995;19(1):8190.Google Scholar
Iacob, S, Cicinnati, VR, Dechêne, A, Lindemann, M, Heinemann, FM, Rebmann, V, et al. Genetic, Immunological and Clinical Risk Factors for Biliary Strictures Following Liver Transplantation. Liver International: Official Journal of the International Association for the Study of the Liver. 2012;32(8):1253–61.CrossRefGoogle ScholarPubMed
Manez, R, Kobayashi, M, Takaya, S, Bronsther, O, Kramer, D, Bonet, H, et al. Humoral Rejection Associated with Antidonor Lymphocytotoxic Antibodies Following Liver Transplantation. Transplantation Proceedings. 1993;25(1 Pt 2):888–90.Google Scholar
Musat, AI, Agni, RM, Wai, PY, Pirsch, JD, Lorentzen, DF, Powell, A, et al. The Significance of Donor-specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(3):500–10.Google Scholar
Bellamy, CO. Complement C4d Immunohistochemistry in the Assessment of Liver Allograft Biopsy Samples: Applications and Pitfalls. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(7):747–50.Google Scholar
Grabhorn, E, Binder, TM, Obrecht, D, Brinkert, F, Lehnhardt, A, Herden, U, et al. Long-term Clinical Relevance of De Novo Donor-specific Antibodies after Pediatric Liver Transplantation. Transplantation. 2015.Google Scholar
Markiewicz-Kijewska, M, Kaliciński, P, Kluge, P, Piątosa, B, Jankowska, I, Rękawek, A, et al. Immunological Factors and Liver Fibrosis in Pediatric Liver Transplant Recipients. Ann Transplant. 2015;20:279–84.Google Scholar
Wozniak, LJ, Hickey, MJ, Venick, RS, Vargas, JH, Farmer, DG, Busuttil, RW, et al. Donor-specific HLA Antibodies Are Associated with Late Allograft Dysfunction after Pediatric Liver Transplantation. Transplantation. 2015.Google Scholar
Ohe, H, Uchida, Y, Yoshizawa, A, Hirao, H, Taniguchi, M, Maruya, E, et al. Association of Anti-human Leukocyte Antigen and Anti-angiotensin II Type 1 Receptor Antibodies with Liver Allograft Fibrosis after Immunosuppression Withdrawal. Transplantation. 2014;98(10):1105–11.Google Scholar
Kosola, S, Lampela, H, Jalanko, H, Makisalo, H, Lohi, J, Arola, J, et al. Low-dose Steroids Associated with Milder Histological Changes after Pediatric Liver Transplantation. Liver Transpl. 2013;19(2):145–54.Google Scholar
Miyagawa-Hayashino, A, Yoshizawa, A, Uchida, Y, Egawa, H, Yurugi, K, Masuda, S, et al. Progressive Graft Fibrosis and Donor-specific Human Leukocyte Antigen Antibodies in Pediatric Late Liver Allografts. Liver Transpl. 2012;18(11):1333–42.Google Scholar
Yamada, H, Kondou, H, Kimura, T, Ikeda, K, Tachibana, M, Hasegawa, Y, et al. Humoral Immunity Is Involved in the Development of Pericentral Fibrosis after Pediatric Live Donor Liver Transplantation. Pediatr Transplant. 2012;16(8):858–65.CrossRefGoogle ScholarPubMed
Girnita, A, Mazariegos, GV, Castellaneta, A, Reyes, J, Bentlejewski, C, Thomson, AW, et al. Liver Transplant Recipients Weaned off Immunosuppression Lack Circulating Donor-specific Antibodies. Hum Immunol. 2010;71(3):274–6.Google Scholar
Kaneku, H, O’Leary, JG, Banuelos, N, Jennings, LW, Susskind, BM, Klintmalm, GB, et al. De Novo Donor-specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients. Am J Transplant. 2013;13(6):1541–8.Google Scholar
O’Leary, JG, Cai, J, Freeman, R, Banuelos, N, Hart, B, Johnson, M, et al. Proposed Diagnostic Criteria for Chronic Antibody-mediated Rejection in Liver Allografts. Am J Transplant. 2015.Google Scholar
Yoshitomi, M, Koshiba, T, Haga, H, Li, Y, Zhao, X, Cheng, D, et al. Requirement of Protocol Biopsy before and after Complete Cessation of Immunosuppression after Liver Transplantation. Transplantation. 2009;87(4):606–14.Google Scholar
Egawa, H, Miyagawa-Hayashino, A, Haga, H, Teramukai, S, Yoshizawa, A, Ogawa, K, et al. Non-inflammatory Centrilobular Sinusoidal Fibrosis in Pediatric Liver Transplant Recipients under Tacrolimus Withdrawal. Hepatology Research: The Official Journal of the Japan Society of Hepatology. 2012;42(9):895903.Google Scholar
Demetris, AJ, Adeyi, O, Bellamy, CO, Clouston, A, Charlotte, F, Czaja, A, et al. Liver Biopsy Interpretation for Causes of Late Liver Allograft Dysfunction. Hepatology. 2006;44(2):489501.Google Scholar
Demetris, AJ, Lunz, JG 3rd, Randhawa, P, Wu, T, Nalesnik, M, Thomson, AW. Monitoring of Human Liver and Kidney Allograft Tolerance: A Tissue/Histopathology Perspective. Transpl Int. 2009;22(1):120–41.Google Scholar
Benitez, C, Londono, MC, Miquel, R, Manzia, TM, Abraldes, JG, Lozano, JJ, et al. Prospective Multicenter Clinical Trial of Immunosuppressive Drug Withdrawal in Stable Adult Liver Transplant Recipients. Hepatology. 2013.Google Scholar
Feng, S, Demetris, AJ, Ekong, U, Girnita, A, Kanaparthi, S, Soppe, C, et al., editors. Serum and Tissue DSA Subclass, Stellate and Endothelial Phenotype Monitoring in ITN029ST Tolerance Pediatric Liver Transplant Recipients over 5+ Years of Follow-up. Joint International Conference of ILTS, ELITA & LICAGE; 2014; London.Google Scholar
Hubscher, SG. What Is the Long-term Outcome of the Liver Allograft? Journal of Hepatology. 2011;55(3):702–17.Google Scholar
Smith, RN, Colvin, RB. Chronic Alloantibody Mediated Rejection. Semin Immunol. 2012;24(2):115–21.Google Scholar
Bellamy, CO, Herriot, MM, Harrison, DJ, Bathgate, AJ. C4d Immunopositivity Is Uncommon in ABO-compatible Liver Allografts, but Correlates Partially with Lymphocytotoxic Antibody Status. Histopathology. 2007;50(6):739–49.Google Scholar
Iacob, S, Cicinnati, VR, Lindemann, M, Heinemann, FM, Radtke, A, Kaiser, GM, et al. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association with Chronic Liver Allograft Failure. Transplantation. 2015;99(9):1869–75.Google Scholar
Seemayer, CA, Gaspert, A, Nickeleit, V, Mihatsch, MJ. C4d Staining of Renal Allograft Biopsies: A Comparative Analysis of Different Staining Techniques. Nephrol Dial Transplant. 2007;22(2):568–76.Google Scholar
Nadasdy, GM, Bott, C, Cowden, D, Pelletier, R, Ferguson, R, Nadasdy, T. Comparative Study for the Detection of Peritubular Capillary C4d Deposition in Human Renal Allografts Using Different Methodologies. Hum Pathol. 2005;36(11):1178–85.Google Scholar
Bu, X, Zheng, Z, Yu, Y, Zeng, L, Jiang, Y. Significance of C4d Deposition in the Diagnosis of Rejection after Liver Transplantation. Transplant Proc. 2006;38(5):1418–21.Google Scholar
Dankof, A, Schmeding, M, Morawietz, L, Gunther, R, Krukemeyer, MG, Rudolph, B, et al. Portal Capillary C4d Deposits and Increased Infiltration by Macrophages Indicate Humorally Mediated Mechanisms in Acute Cellular Liver Allograft Rejection. Virchows Arch. 2005;447(1):8793.Google Scholar
Jain, A, Mohanka, R, Orloff, M, Abt, P, Romano, J, Bryan, L, et al. Characterization of CD4, CD8, CD56 Positive Lymphocytes and C4d Deposits to Distinguish Acute Cellular Rejection from Recurrent Hepatitis C in Post-liver Transplant Biopsies. Clin Transplant. 2006;20(5):624–33.Google Scholar
Krukemeyer, MG, Moeller, J, Morawietz, L, Rudolph, B, Neumann, U, Theruvath, T, et al. Description of B Lymphocytes and Plasma Cells, Complement, and Chemokines/Receptors in Acute Liver Allograft Rejection. Transplantation. 2004;78(1):6570.Google Scholar
Sakashita, H, Haga, H, Ashihara, E, Wen, MC, Tsuji, H, Miyagawa-Hayashino, A, et al. Significance of C4d Staining in ABO-identical/Compatible Liver Transplantation. Mod Pathol. 2007;20(6):676–84.Google Scholar
Sawada, T, Shimizu, A, Kubota, K, Fuchinoue, S, Teraoka, S. Lobular Damage Caused by Cellular and Humoral Immunity in Liver Allograft Rejection. Clin Transplant. 2005;19(1):110–4.Google Scholar
Troxell, ML, Higgins, JP, Kambham, N. Evaluation of C4d Staining in Liver and Small Intestine Allografts. Arch Pathol Lab Med. 2006;130(10):1489–96.Google Scholar
Bouron-Dal Soglio, D, Rougemont, AL, Herzog, D, Soucy, G, Alvarez, F, Fournet, JC. An Immunohistochemical Evaluation of C4d Deposition in Pediatric Inflammatory Liver Diseases. Human Pathology. 2008;39(7):1103–10.Google Scholar
Aguilera, I, Sousa, JM, Gavilan, F, Gomez, L, Alvarez-Marquez, A, Nunez-Roldan, A. Complement Component 4d Immunostaining in Liver Allografts of Patients with de Novo Immune Hepatitis. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(7):779–88.Google Scholar
Schmeding, M, Dankof, A, Krenn, V, Krukemeyer, MG, Koch, M, Spinelli, A, et al. C4d in Acute Rejection after Liver Transplantation–A Valuable Tool in Differential Diagnosis to Hepatitis C Recurrence. Am J Transplant. 2006;6(3):523–30.Google Scholar
Silva, MA, Mirza, DF, Murphy, N, Richards, DA, Reynolds, GM, Wigmore, SJ, et al. Intrahepatic Complement Activation, Sinusoidal Endothelial Injury, and Lactic Acidosis Are Associated with Initial Poor Function of the Liver after Transplantation. Transplantation. 2008;85(5):718–25.CrossRefGoogle ScholarPubMed
Martelius, T, Halme, L, Arola, J, Hockerstedt, K, Lautenschlager, I. Vascular Deposition of Complement C4d Is Increased in Liver Allografts with Chronic Rejection. Transpl Immunol. 2009;21(4):244–6.Google Scholar
Anonymous. Terminology for Hepatic Allograft Rejection. International Working Party. Hepatology. 1995;22(2):648–54.Google Scholar
Knechtle, SJ, Kwun, J. Unique Aspects of Rejection and Tolerance in Liver Transplantation. Seminars in Liver Disease. 2009;29(1):91101.Google Scholar
Neuberger, J. Incidence, Timing, and Risk Factors for Acute and Chronic Rejection. Liver Transpl Surg. 1999;5(4 Suppl 1):S306.Google Scholar
Demetris, AJ, Ruppert, K, Dvorchik, I, Jain, A, Minervini, M, Nalesnik, MA, et al. Real-time Monitoring of Acute Liver-allograft Rejection Using the BANFF Schema. Transplantation. 2002;74(9):1290–6.CrossRefGoogle ScholarPubMed
Germani, G, Rodriguez-Castro, K, Russo, FP, Senzolo, M, Zanetto, A, Ferrarese, A, et al. Markers of Acute Rejection and Graft Acceptance in Liver Transplantation. World J Gastroenterol. 2015;21(4):1061–8.Google Scholar
Neil, DA, Hubscher, SG. Current Views on Rejection Pathology in Liver Transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation. 2010;23(10):971–83.Google Scholar
Uemura, T, Ikegami, T, Sanchez, EQ, Jennings, LW, Narasimhan, G, McKenna, GJ, et al. Late Acute Rejection after Liver Transplantation Impacts Patient Survival. Clin Transplant. 2008;22(3):316–23.Google Scholar
Neil, DA, Hubscher, SG. Are Parenchymal Changes in Early Post-transplant Biopsies Related to Preservation-Reperfusion Injury or Rejection? Transplantation. 2001;71(11):1566–72.Google Scholar
Anonymous. BANFF Schema for Grading Liver Allograft Rejection: An International Consensus Document. Hepatology. 1997;25(3):658–63.Google Scholar
Yeh, MM, Larson, AM, Tung, BY, Swanson, PE, Upton, MP. Endotheliitis in Chronic Viral Hepatitis: A Comparison with Acute Cellular Rejection and Non-alcoholic Steatohepatitis. The American Journal of Surgical Pathology. 2006;30(6):727–33.Google Scholar
Demetris, AJ, Lasky, S, Van Thiel, DH, Starzl, TE, Dekker, A. Pathology of Hepatic Transplantation: A Review of 62 Adult Allograft Recipients Immunosuppressed with a Cyclosporine/Steroid Regimen. Am J Pathol. 1985;118(1):151–61.Google Scholar
McCaughan, GW, Davies, JS, Waugh, JA, Bishop, GA, Hall, BM, Gallagher, ND, et al. A Quantitative Analysis of T Lymphocyte Populations in Human Liver Allografts Undergoing Rejection: The Use of Monoclonal Antibodies and Double Immunolabeling. Hepatology. 1990;12(6):1305–13.Google Scholar
Steinhoff, G, Behrend, M, Wonigeit, K. Expression of Adhesion Molecules on Lymphocytes/Monocytes and Hepatocytes in Human Liver Grafts. Hum Immunol. 1990;28(2):123–7.Google Scholar
Demetris, AJ, Belle, SH, Hart, J, Lewin, K, Ludwig, J, Snover, DC, et al. Intraobserver and Interobserver Variation in the Histopathological Assessment of Liver Allograft Rejection. The Liver Transplantation Database (LTD) Investigators. Hepatology. 1991;14(5):751–5.Google Scholar
Cong, WM, Zhang, SY, Wang, ZL, Xue, L, Liu, YS, Zhang, SH. [Pathologic Diagnosis of 1123 Post-transplant Liver Biopsies from 665 Liver Transplant Patients]. Zhonghua Bing Li Xue Za Zhi. 2005;34(11):716–9.Google Scholar
Netto, GJ, Watkins, DL, Williams, JW, Colby, TV, dePetris, G, Sharkey, FE, et al. Interobserver Agreement in Hepatitis C Grading and Staging and in the BANFF Grading Schema for Acute Cellular Rejection: The “Hepatitis C 3” Multi-institutional Trial Experience. Arch Pathol Lab Med. 2006;130(8):1157–62.Google Scholar
Demirhan, B, Bilezikci, B, Haberal, AN, Sevmis, S, Arat, Z, Haberal, M. Hepatic Parenchymal Changes and Histologic Eosinophilia as Predictors of Subsequent Acute Liver Allograft Rejection. Liver Transpl. 2008;14(2):214–9.Google Scholar
Hubscher, S. Diagnosis and Grading of Liver Allograft Rejection: A European Perspective. Transplant Proc. 1996;28(1):504–7.Google Scholar
Ishak, K, Baptista, A, Bianchi, L, Callea, F, De Groote, J, Gudat, F, et al. Histological Grading and Staging of Chronic Hepatitis. Journal of Hepatology. 1995;22(6):696–9.Google Scholar
Tsamandas, AC, Jain, AB, Felekouras, ES, Fung, JJ, Demetris, AJ, Lee, RG. Central Venulitis in the Allograft Liver: A Clinicopathologic Study. Transplantation. 1997;64(2):252–7.Google Scholar
Krasinskas, AM, Ruchelli, ED, Rand, EB, Chittams, JL, Furth, EE. Central Venulitis in Pediatric Liver Allografts. Hepatology. 2001;33(5):1141–7.Google Scholar
Krasinskas, AM, Demetris, AJ, Poterucha, JJ, Abraham, SC. The Prevalence and Natural History of Untreated Isolated Central Perivenulitis in Adult Allograft Livers. Liver Transpl. 2008;14(5):625–32.Google Scholar
Sanei, MH, Schiano, TD, Sempoux, C, Fan, C, Fiel, MI. Acute Cellular Rejection Resulting in Sinusoidal Obstruction Syndrome and Ascites Postliver Transplantation. Transplantation. 2011;92(10):1152–8.Google Scholar
Demetris, AJ, Duquesnoy, RJ, Fung, JJ, Murase, N, Nalesnik, M, Randhawa, P, et al. Pathophysiology of Chronic Allograft Rejection [Internet]. Medscape Transplantation. 2000. Available from: www.transplantation.medscape.com/Medscape/transplantation/ClinicalMgmt/CM.v02/public/index.CM.v02.html.Google Scholar
Walter, T, Dumortier, J, Guillaud, O, Hervieu, V, Paliard, P, Scoazec, JY, et al. Rejection under Alpha Interferon Therapy in Liver Transplant Recipients. Am J Transplant. 2007;7(1):177–84.Google Scholar
Stanca, CM, Fiel, MI, Kontorinis, N, Agarwal, K, Emre, S, Schiano, TD. Chronic Ductopenic Rejection in Patients with Recurrent Hepatitis C Virus Treated with Pegylated Interferon Alfa-2a and Ribavirin. Transplantation. 2007;84(2):180–6.Google Scholar
Blakolmer, K, Gaulard, P, Mannhalter, C, Swerdlow, S, Fassati, LR, Rossi, G, et al. Unusual Peripheral T Cell Lymphoma Presenting as Acute Liver Failure and Reappearing in the Liver Allograft. Transplantation. 2000;70(12):1802–5.Google Scholar
Blakolmer, K, Jain, A, Ruppert, K, Gray, E, Duquesnoy, R, Murase, N, et al. Chronic Liver Allograft Rejection in a Population Treated Primarily with Tacrolimus as Baseline Immunosuppression: Long-term Follow-up and Evaluation of Features for Histopathological Staging. Transplantation. 2000;69(11):2330–6.Google Scholar
Demetris, AJ. Spectrum of Chronic Hepatic Allograft Rejection and Arteriopathy and the Controversy of Centrilobular Necrosis. Liver Transpl. 2000;6(1):102–3.Google Scholar
Evans, PC, Smith, S, Hirschfield, G, Rigopoulou, E, Wreghitt, TG, Wight, DG, et al. Recipient HLA-DR3, Tumour Necrosis Factor-alpha Promoter Allele-2 (Tumour Necrosis Factor-2) and Cytomegalovirus Infection are Interrelated Risk Factors for Chronic Rejection of Liver Grafts. Journal of Hepatology. 2001;34(5):711–5.Google Scholar
O’Leary, JG, Kaneku, H, Susskind, BM, Jennings, LW, Neri, MA, Davis, GL, et al. High Mean Fluorescence Intensity Donor-specific Anti-HLA Antibodies Associated with Chronic Rejection Postliver Transplant. Am J Transplant. 2011;11(9):1868–76.Google Scholar
Pappo, O, Ramos, H, Starzl, TE, Fung, JJ, Demetris, AJ. Structural Integrity and Identification of Causes of Liver Allograft Dysfunction Occurring More Than 5 Years after Transplantation. American Journal of Surgical Pathology. 1995;19(2):192206.Google Scholar
Demetris, AJ, Murase, N, Starzl, TE, Fung, JJ. Pathology of Chronic Rejection: An Overview of Common Findings and Observations about Pathogenic Mechanisms and Possible Prevention. Graft. 1998;1:52–9.Google Scholar
Blakolmer, K, Seaberg, EC, Batts, K, Ferrell, L, Markin, R, Wiesner, R, et al. Analysis of the Reversibility of Chronic Liver Allograft Rejection Implications for a Staging Schema. Am J Surg Pathol. 1999;23(11):1328–39.Google Scholar
Demetris, AJ, Fung, JJ, Todo, S, McCauley, J, Jain, A, Takaya, S, et al. Conversion of Liver Allograft Recipients from Cyclosporine to FK506 Immunosuppressive Therapy–A Clinicopathologic Study of 96 Patients. Transplantation. 1992;53(5):1056–62.Google Scholar
White, RM, Zajko, AB, Demetris, AJ, Bron, KM, Dekker, A, Starzl, TE. Liver Transplant Rejection: Angiographic Findings in 35 Patients. AJR Am J Roentgenol. 1987;148(6):1095–8.Google Scholar
Freese, DK, Snover, DC, Sharp, HL, Gross, CR, Savick, SK, Payne, WD. Chronic Rejection after Liver Transplantation: A Study of Clinical, Histopathological and Immunological Features. Hepatology. 1991;13(5):882–91.Google Scholar
Hubscher, SG, Buckels, JA, Elias, E, McMaster, P, Neuberger, JM. Reversible Vanishing Bile Duct Syndrome after Liver Transplantation: Report of 6 Cases. Transplantation Proceedings. 1991;23(1 Pt 2):1415–6.Google Scholar
Hubscher, SG, Buckels, JA, Elias, E, McMaster, P, Neuberger, J. Vanishing Bile-duct Syndrome Following Liver Transplantation–Is It Reversible? Transplantation. 1991;51(5):1004–10.Google Scholar
van den Heuvel, MC, de Jong, KP, Boot, M, Slooff, MJ, Poppema, S, Gouw, AS. Preservation of Bile Ductules Mitigates Bile Duct Loss. Am J Transplant. 2006;6(11):2660–71.Google Scholar
Demetris, A, Adams, D, Bellamy, C, Blakolmer, K, Clouston, A, Dhillon, AP, et al. Update of the International BANFF Schema for Liver Allograft Rejection: Working Recommendations for the Histopathologic Staging and Reporting of Chronic Rejection. An International Panel. Hepatology. 2000;31(3):792–9.Google Scholar
O’Keeffe, C, Baird, AW, Nolan, N, McCormick, PA. Mast Cell Hyperplasia in Chronic Rejection after Liver Transplantation. Liver Transpl. 2002;8(1):50–7.Google Scholar
Sasaki, M, Ikeda, H, Haga, H, Manabe, T, Nakanuma, Y. Frequent Cellular Senescence in Small Bile Ducts in Primary Biliary Cirrhosis: A Possible Role in Bile Duct Loss. The Journal of Pathology. 2005;205(4):451–9.Google Scholar
Rygiel, KA, Robertson, H, Willet, JD, Brain, JG, Burt, AD, Jones, DE, et al. T Cell-mediated Biliary Epithelial-to-Mesenchymal Transition in Liver Allograft Rejection. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2010;16(5):567–76.Google Scholar
Crawford, AR, Lin, XZ, Crawford, JM. The Normal Adult Human Liver Biopsy: A Quantitative Reference Standard. Hepatology. 1998;28(2):323–31.Google Scholar
Oguma, S, Belle, S, Starzl, TE, Demetris, AJ. A Histometric Analysis of Chronically Rejected Human Liver Allografts: Insights into the Mechanisms of Bile Duct Loss: Direct Immunologic and Ischemic Factors. Hepatology. 1989;9(2):204–9.Google Scholar
Moreira, RK, Chopp, W, Washington, MK. The Concept of Hepatic Artery-bile Duct Parallelism in the Diagnosis of Ductopenia in Liver Biopsy Samples. The American Journal of Surgical Pathology. 2011;35(3):392403.Google Scholar
Matsumoto, Y, McCaughan, GW, Painter, DM, Bishop, GA. Evidence that Portal Tract Microvascular Destruction Precedes Bile Duct Loss in Human Liver Allograft Rejection. Transplantation. 1993;56(1):6975.Google Scholar
Neil, DA, Hubscher, SG. Histologic and Biochemical Changes during the Evolution of Chronic Rejection of Liver Allografts. Hepatology. 2002;35(3):639–51.Google Scholar
Nakazawa, Y, Jonsson, JR, Walker, NI, Kerlin, P, Steadman, C, Lynch, SV, et al. Fibrous Obliterative Lesions of Veins Contribute to Progressive Fibrosis in Chronic Liver Allograft Rejection. Hepatology. 2000;32(6):1240–7.Google Scholar
Rubin, RH, Tolkoff-Rubin, NE. Opportunistic Infections in Renal Allograft Recipients. Transplantation Proceedings. 1988;20(6 Suppl 8):12–8.Google Scholar
Kalil, AC, Opal, SM. Sepsis in the Severely Immunocompromised Patient. Current Infectious Disease Reports. 2015;17(6):487.Google Scholar
Fishman, JA. Infections in Immunocompromised Hosts and Organ Transplant Recipients: Essentials. Liver Transpl. 2011;17 Suppl 3:S347.Google Scholar
Helfrich, M, Ison, MG. Opportunistic Infections Complicating Solid Organ Transplantation with Alemtuzumab Induction. Transpl Infect Dis. 2015.Google Scholar
Pedersen, M, Seetharam, A. Infections after Orthotopic Liver Transplantation. J Clin Exp Hepatol. 2014;4(4):347–60.Google Scholar
Bruminhent, J, Razonable, RR. Management of Cytomegalovirus Infection and Disease in Liver Transplant Recipients. World J Hepatol. 2014;6(6):370–83.Google Scholar
Fehr, T, Cippa, PE, Mueller, NJ. Cytomegalovirus Post Kidney Transplantation: Prophylaxis versus Pre-emptive Therapy? Transpl Int. 2015.Google Scholar
Bai, X, Rogers, BB, Harkins, PC, Sommerauer, J, Squires, R, Rotondo, K, et al. Predictive Value of Quantitative PCR-based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients. J Mol Diagn. 2000;2(4):191201.Google Scholar
Neoh, CF, Snell, G, Levvey, B, Morrissey, CO, Stewart, K, Kong, DC. Antifungal Prophylaxis in Lung Transplantation. International Journal of Antimicrobial Agents. 2014;44(3):194202.Google Scholar
Razonable, RR, Emery, VC. Management of CMV Infection and Disease in Transplant Patients. 27–29 February 2004. Herpes: The Journal of the IHMF. 2004;11(3):7786.Google Scholar
Lautenschlager, I. CMV Infection, Diagnosis and Antiviral Strategies after Liver Transplantation. Transplant International: Official Journal of the European Society for Organ Transplantation. 2009;22(11):1031–40.Google Scholar
Razonable, RR. Cytomegalovirus Infection after Liver Transplantation: Current Concepts and Challenges. World Journal of Gastroenterology: WJG. 2008;14(31):4849–60.Google Scholar
Eid, AJ, Bakri, SJ, Kijpittayarit, S, Razonable, RR. Clinical Features and Outcomes of Cytomegalovirus Retinitis after Transplantation. Transpl Infect Dis. 2008;10(1):13–8.Google Scholar
Demetris, AJ, Nalesnik, M, Randhawa, P, Wu, T, Minervini, M, Lai, C, et al. Histologic Patterns of Rejection and Other Causes of Liver Dysfunction. In: Busuttil, RW, Klintmalm, GB, editors. Transplantation of the Liver. Philadelphia: Elsevier Saunders; 2005. p. 1057–128.Google Scholar
Barkholt, LM, Ehrnst, A, Veress, B. Clinical Use of Immunohistopathologic Methods for the Diagnosis of Cytomegalovirus Hepatitis in Human Liver Allograft Biopsy Specimens. Scand J Gastroenterol. 1994;29(6):553–60.Google Scholar
Mabruk, MJ. In Situ Hybridization: Detecting Viral Nucleic Acid in Formalin-fixed, Paraffin-embedded Tissue Samples. Expert Review of Molecular Diagnostics. 2004;4(5):653–61.Google Scholar
O’Grady, JG, Alexander, GJ, Sutherland, S, Donaldson, PT, Harvey, F, Portmann, B, et al. Cytomegalovirus Infection and Donor/Recipient HLA Antigens: Interdependent Co-factors in Pathogenesis of Vanishing Bile-duct Syndrome after Liver Transplantation. Lancet. 1988;2(8606):302–5.Google Scholar
Lautenschlager, I, Hockerstedt, K, Jalanko, H, Loginov, R, Salmela, K, Taskinen, E, et al. Persistent Cytomegalovirus in Liver Allografts with Chronic Rejection. Hepatology. 1997;25(1):190–4.Google Scholar
Paya, CV, Wiesner, RH, Hermans, PE, Larson-Keller, JJ, Ilstrup, DM, Krom, RA, et al. Lack of Association between Cytomegalovirus Infection, HLA Matching and the Vanishing Bile Duct Syndrome after Liver Transplantation. Hepatology. 1992;16(1):6670.Google Scholar
Nourse, JP, Jones, K, Gandhi, MK. Epstein-Barr Virus-related Post-transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(5):888–95.Google Scholar
Cesarman, E. Gammaherpesvirus and Lymphoproliferative Disorders in Immunocompromised Patients. Cancer Lett. 2011;305(2):163–74.Google Scholar
Nalesnik, MA. Clinicopathologic Characteristics of Post-transplant Lymphoproliferative Disorders. Recent Results Cancer Res. 2002;159:918.Google Scholar
Allen, U, Preiksaitis, J. Epstein-barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients. Am J Transplant. 2009;9 Suppl 4:S8796.Google Scholar
Verghese, PS, Schmeling, DO, Knight, JA, Matas, AJ, Balfour, HH Jr. The Impact of Donor Viral Replication at Transplant on Recipient Infections Posttransplant: A Prospective Study. Transplantation. 2015;99(3):602–8.Google Scholar
Jain, A, Nalesnik, M, Reyes, J, Pokharna, R, Mazariegos, G, Green, M, et al. Posttransplant Lymphoproliferative Disorders in Liver Transplantation: A 20-year experience. Ann Surg. 2002;236(4):429–36.Google Scholar
Hartmann, C, Schuchmann, M, Zimmermann, T. Posttransplant Lymphoproliferative Disease in Liver Transplant Patients. Current Infectious Disease Reports. 2011;13(1):53–9.Google Scholar
Narkewicz, MR, Green, M, Dunn, S, Millis, M, McDiarmid, S, Mazariegos, G, et al. Decreasing Incidence of Symptomatic Epstein-Barr Virus Disease and Posttransplant Lymphoproliferative Disorder in Pediatric Liver Transplant Recipients: Report of the Studies of Pediatric Liver Transplantation Experience. Liver Transpl. 2013;19(7):730–40.Google Scholar
Koch, DG, Christiansen, L, Lazarchick, J, Stuart, R, Willner, IR, Reuben, A. Posttransplantation Lymphoproliferative Disorder–The Great Mimic in Liver Transplantation: Appraisal of the Clinicopathologic Spectrum and the Role of Epstein-Barr Virus. Liver Transpl. 2007;13(6):904–12.Google Scholar
Niller, HH, Wolf, H, Minarovits, J. Regulation and Dysregulation of Epstein-Barr Virus Latency: Implications for the Development of Autoimmune Diseases. Autoimmunity. 2008;41(4):298328.Google Scholar
Randhawa, PS, Markin, RS, Starzl, TE, Demetris, AJ. Epstein-Barr Virus-associated Syndromes in Immunosuppressed Liver Transplant Recipients. Clinical Profile and Recognition on Routine Allograft Biopsy. Am J Surg Pathol. 1990;14(6):538–47.Google Scholar
Randhawa, PS, Jaffe, R, Demetris, AJ, Nalesnik, M, Starzl, TE, Chen, YY, et al. The Systemic Distribution of Epstein-Barr Virus Genomes in Fatal Post-Transplantation Lymphoproliferative Disorders. An in Situ Hybridization Study. Am J Pathol. 1991;138(4):1027–33.Google Scholar
Randhawa, PS, Jaffe, R, Demetris, AJ, Nalesnik, M, Starzl, TE, Chen, YY, et al. Expression of Epstein-Barr Virus-encoded Small RNA (by the EBER-1 Gene) in Liver Specimens from Transplant Recipients with Post-transplantation Lymphoproliferative Disease. N Engl J Med. 1992;327(24):1710–4.Google Scholar
Jha, B, Gajendra, S, Sachdev, R, Goel, S, Sahni, T, Raina, V. Prompt Diagnosis and Management of Epstein-Barr Virus-associated Post-transplant Lymphoproliferative Disorder and Hemophagocytosis: A Dreaded Complication in a Post-liver Transplant Child. Pediatr Transplant. 2015.Google Scholar
Cockfield, SM. Identifying the Patient at Risk for Post-transplant Lymphoproliferative Disorder. Transpl Infect Dis. 2001;3(2):70–8.Google Scholar
Bakker, NA, van Imhoff, GW, Verschuuren, EA, van Son, WJ. Presentation and Early Detection of Post-transplant Lymphoproliferative Disorder after Solid Organ Transplantation. Transpl Int. 2007;20(3):207–18.Google Scholar
Jamalidoust, M, Geramizadeh, B, Pouladfar, G, Namayandeh, M, Asaie, S, Aliabadi, N, et al. Epstein-Barr Virus DNAemia in Iranian Liver Transplant Recipients and Assessment of Its Variation in Posttransplant Lymphproliferative Disorder Patients by Quantitative Polymerase Chain Reaction Assay. Exp Clin Transplant. 2015;13 Suppl 1:306–11.Google Scholar
Randhawa, P, Blakolmer, K, Kashyap, R, Raikow, R, Nalesnik, M, Demetris, AJ, et al. Allograft Liver Biopsy in Patients with Epstein-Barr Virus-associated Posttransplant Lymphoproliferative Disease. Am J Surg Pathol. 2001;25(3):324–30.Google Scholar
Loginov, R, Halme, L, Arola, J, Hockerstedt, K, Lautenschlager, I. Intragraft Immunological Events Associated with EBV DNAemia in Liver Transplant Patients. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 2010;118(11):888–94.Google Scholar
Petrova, M, Kamburov, V. Epstein-Barr Virus: Silent Companion or Causative Agent of Chronic Liver Disease? World Journal of Gastroenterology: WJG. 2010;16(33):4130–4.Google Scholar
Harris, N, Swerdlow, S, Frizzera, G, Knowles, D, editors. Post-transplant Lymphoproliferative Disorders. Lyon: IARC Press; 2001.Google Scholar
Singavi, AK, Harrington, AM, Fenske, TS. Post-transplant Lymphoproliferative Disorders. Cancer Treatment and Research. 2015;165:305–27.Google Scholar
Hubscher, SG, Williams, A, Davison, SM, Young, LS, Niedobitek, G. Epstein-Barr Virus in Inflammatory Diseases of the Liver and Liver Allografts: An in Situ Hybridization Study. Hepatology. 1994;20(4 Pt 1):899907.Google Scholar
Kobayashi, M, Asano, N, Fukushima, M, Honda, T. Three Different Histological Subtypes of Epstein-Barr Virus-negative Post-transplant Lymphoproliferative Disorder in a Patient with Hepatitis C Infection. International Journal of Hematology. 2014;100(3):307–11.Google Scholar
Morscio, J, Dierickx, D, Ferreiro, JF, Herreman, A, Van Loo, P, Bittoun, E, et al. Gene Expression Profiling Reveals Clear Differences between EBV-positive and EBV-Negative Posttransplant Lymphoproliferative Disorders. Am J Transplant. 2013;13(5):1305–16.Google Scholar
Montalbano, M, Slapak-Green, GI, Neff, GW. Fulminant Hepatic Failure from Herpes Simplex Virus: Post Liver Transplantation Acyclovir Therapy and Literature Review. Transplantation Proceedings. 2005;37(10):4393–6.Google Scholar
Kusne, S, Schwartz, M, Breinig, MK, Dummer, JS, Lee, RE, Selby, R, et al. Herpes Simplex Virus Hepatitis after Solid Organ Transplantation in Adults. J Infect Dis. 1991;163(5):1001–7.Google Scholar
Javed, S, Javed, SA, Tyring, SK. Varicella Vaccines. Current Opinion in Infectious Diseases. 2011.Google Scholar
Lucey, MR, Terrault, N, Ojo, L, Hay, JE, Neuberger, J, Blumberg, E, et al. Long-term Management of the Successful Adult Liver Transplant: 2012 Practice Guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):326.Google Scholar
Basse, G, Mengelle, C, Kamar, N, Ribes, D, Selves, J, Cointault, O, et al. Disseminated Herpes Simplex Type-2 (HSV-2) Infection after Solid-organ Transplantation. Infection. 2008;36(1):62–4.Google Scholar
Riediger, C, Sauer, P, Matevossian, E, Muller, MW, Buchler, P, Friess, H. Herpes Simplex Virus Sepsis and Acute Liver Failure. Clinical Transplantation. 2009;23 Suppl 21:3741.Google Scholar
Kusne, S, Martin, M, Shapiro, R, Jordan, M, Fung, J, Alessiani, M, et al. Early Infections in Kidney Transplant Recipients under FK 506. Transplantation Proceedings. 1991;23(1 Pt 2):956–7.Google Scholar
Abdel Massih, RC, Razonable, RR. Human Herpesvirus 6 Infections after Liver Transplantation. World J Gastroenterol. 2009;15(21):2561–9.Google Scholar
Razonable, RR, Rivero, A, Brown, RA, Hart, GD, Espy, MJ, van Cruijsen, H, et al. Detection of Simultaneous Beta-herpesvirus Infections in Clinical Syndromes due to Defined Cytomegalovirus Infection. Clin Transplant. 2003;17(2):114–20.Google Scholar
Lautenschlager, I, Razonable, RR. Human Herpesvirus-6 Infections in Kidney, Liver, Lung, and Heart Transplantation: Review. Transpl Int. 2012;25(5):493502.Google Scholar
Lautenschlager, I, Hockerstedt, K, Linnavuori, K, Taskinen, E. Human Herpesvirus-6 Infection after Liver Transplantation. Clin Infect Dis. 1998;26(3):702–7.Google Scholar
Lautenschlager, I, Harma, M, Hockerstedt, K, Linnavuori, K, Loginov, R, Taskinen, E. Human Herpesvirus-6 Infection Is Associated with Adhesion Molecule Induction and Lymphocyte Infiltration in Liver Allografts. Journal of Hepatology. 2002;37(5):648–54.Google Scholar
Potenza, L, Luppi, M, Barozzi, P, Rossi, G, Cocchi, S, Codeluppi, M, et al. HHV-6A in Syncytial Giant-cell Hepatitis. The New England Journal of Medicine. 2008;359(6):593602.Google Scholar
Andreoni, M, Goletti, D, Pezzotti, P, Pozzetto, A, Monini, P, Sarmati, L, et al. Prevalence, Incidence and Correlates of HHV-8/KSHV Infection and Kaposi’s Sarcoma in Renal and Liver Transplant Recipients. J Infect. 2001;43(3):195–9.Google Scholar
Pietrosi, G, Vizzini, G, Pipitone, L, Di Martino, G, Minervini, MI, Lo Iacono, G, et al. Primary and Reactivated HHV8 Infection and Disease after Liver Transplantation: A Prospective Study. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011;11(12):2715–23.Google Scholar
Aseni, P, Vertemati, M, Minola, E, Arcieri, K, Bonacina, E, Camozzi, M, et al. Kaposi’s Sarcoma in Liver Transplant Recipients: Morphological and Clinical Description. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2001;7(9):816–23.Google Scholar
Benhammane, H, Mentha, G, Tschanz, E, El Mesbahi, O, Dietrich, PY. Visceral Kaposi’s Sarcoma Related to Human Herpesvirus-8 in Liver Transplant Recipient: Case Report and Literature Review. Case Reports in Oncological Medicine. 2012;2012:137291.Google Scholar
Lebbe, C, Porcher, R, Marcelin, AG, Agbalika, F, Dussaix, E, Samuel, D, et al. Human Herpesvirus 8 (HHV8) Transmission and Related Morbidity in Organ Recipients. Am J Transplant. 2013;13(1):207–13.Google Scholar
Pozo, F, Tenorio, A, de la Mata, M, de Ory, F, Torre-Cisneros, J. Persistent Human Herpesvirus 8 Viremia before Kaposi’s Sarcoma Development in a Liver Transplant Recipient. Transplantation. 2000;70(2):395–7.Google Scholar
Koneru, B, Jaffe, R, Esquivel, CO, Kunz, R, Todo, S, Iwatsuki, S, et al. Adenoviral Infections in Pediatric Liver Transplant Recipients. Jama. 1987;258(4):489–92.Google Scholar
Michaels, MG, Green, M, Wald, ER, Starzl, TE. Adenovirus Infection in Pediatric Liver Transplant Recipients. J Infect Dis. 1992;165(1):170–4.Google Scholar
Saad, RS, Demetris, AJ, Lee, RG, Kusne, S, Randhawa, PS. Adenovirus Hepatitis in the Adult Allograft Liver. Transplantation. 1997;64(10):1483–5.Google Scholar
Perez, D, McCormack, L, Petrowsky, H, Jochum, W, Mullhaupt, B, Clavien, PA. Successful Outcome of Severe Adenovirus Hepatitis of the Allograft Following Liver Transplantation. Transplant Infectious Disease: An Official Journal of the Transplantation Society. 2007;9(4):318–22.Google Scholar
Hoffman, JA. Adenoviral Disease in Pediatric Solid Organ Transplant Recipients. Pediatric Transplantation. 2006;10(1):1725.Google Scholar
Kerensky, T, Hasan, A, Schain, D, Trikha, G, Liu, C, Rand, K, et al. Histopathologic Resolution of Adult Liver Transplantation Adenovirus Hepatitis with Cidofovir and Intravenous Immunoglobulin: A Case Report. Transplantation Proceedings. 2013;45(1):293–6.Google Scholar
Ronan, BA, Agrwal, N, Carey, EJ, De Petris, G, Kusne, S, Seville, MT, et al. Fulminant Hepatitis due to Human Adenovirus. Infection. 2014;42(1):105–11.Google Scholar
Cimsit, B, Tichy, EM, Patel, SB, Rosencrantz, R, Emre, S. Treatment of Adenovirus Hepatitis with Cidofovir in a Pediatric Liver Transplant Recipient. Pediatr Transplant. 2012;16(3):E903.Google Scholar
McGrath, D, Falagas, ME, Freeman, R, Rohrer, R, Fairchild, R, Colbach, C, et al. Adenovirus Infection in Adult Orthotopic Liver Transplant Recipients: Incidence and Clinical Significance. J Infect Dis. 1998;177(2):459–62.Google Scholar
Ohori, NP, Michaels, MG, Jaffe, R, Williams, P, Yousem, SA. Adenovirus Pneumonia in Lung Transplant Recipients. Hum Pathol. 1995;26(10):1073–9.Google Scholar
Zarrinpar, A, Kaldas, F, Busuttil, RW. Liver Transplantation for Hepatocellular Carcinoma: An Update. Hepatobiliary & Pancreatic Diseases International: HBPD INT. 2011;10(3):234–42.Google Scholar
Washburn, K, Halff, G. Hepatocellular Carcinoma and Liver Transplantation. Curr Opin Organ Transplant. 2011;16(3):297300.Google Scholar
Chok, K. Management of Recurrent Hepatocellular Carcinoma after Liver Transplant. World J Hepatol. 2015;7(8):1142–8.Google Scholar
Schmeding, M, Neumann, UP. Liver Transplant for Cholangiocarcinoma: A Comeback? Exp Clin Transplant. 2015;13(4):301–8.Google Scholar
Grossman, EJ, Millis, JM. Liver Transplantation for Non-hepatocellular Carcinoma Malignancy: Indications, Limitations, and Analysis of the Current Literature. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2010;16(8):930–42.Google Scholar
Hunt, J, Gordon, FD, Jenkins, RL, Lewis, WD, Khettry, U. Sarcoidosis with Selective Involvement of a Second Liver Allograft: Report of a Case and Review of the Literature. Mod Pathol. 1999;12(3):325–8.Google Scholar
Vanatta, JM, Modanlou, KA, Dean, AG, Nezakatgoo, N, Campos, L, Nair, S, et al. Outcomes of Orthotopic Liver Transplantation for Hepatic Sarcoidosis: An Analysis of the United Network for Organ Sharing/Organ Procurement and Transplantation Network Data Files for a Comparative Study with Cholestatic Liver Diseases. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(9):1027–34.Google Scholar
Pappo, O, Yunis, E, Jordan, JA, Jaffe, R, Mateo, R, Fung, J, et al. Recurrent and de Novo Giant Cell Hepatitis after Orthotopic Liver Transplantation. Am J Surg Pathol. 1994;18(8):804–13.Google Scholar
Starzl, TE, Demetris, AJ. Liver Transplantation: A 31-year Perspective. Part I. Curr Probl Surg. 1990;27(2):55116.Google Scholar
Starzl, TE, Demetris, AJ. Liver Transplantation: A 31-year Perspective. Part II. Curr Probl Surg. 1990;27(3):123–78.Google Scholar
Starzl, TE, Demetris, AJ. Liver Transplantation: A 31-year Perspective. Part III. Curr Probl Surg. 1990;27(4):187240.Google Scholar
Huang, J. Ethical and Legislative Perspectives on Liver Transplantation in the People’s Republic of China. Liver Transpl. 2007;13(2):193–6.Google Scholar
Saab, S, Greenberg, A, Li, E, Bau, SN, Durazo, F, El-Kabany, M, et al. Sofosbuvir and Simeprevir Is Effective for Recurrent Hepatitis C in Liver Transplant Recipients. Liver International: Official Journal of the International Association for the Study of the Liver. 2015.Google Scholar
Coilly, A, Roche, B, Duclos-Vallee, JC, Samuel, D. Optimal Therapy in Hepatitis C Virus Liver Transplant Patients with Direct Acting Antivirals. Liver International: Official Journal of the International Association for the Study of the Liver. 2015;35 Suppl 1:4450.Google Scholar
Cavallari, A, De Raffele, E, Bellusci, R, Miniero, R, Vivarelli, M, Galli, S, et al. De Novo Hepatitis B and C Viral Infection after Liver Transplantation. World J Surg. 1997;21(1):7884.Google Scholar
Jimenez-Perez, M, Gonzalez-Grande, R, Rando-Munoz, FJ. Management of Recurrent Hepatitis C Virus after Liver Transplantation. World J Gastroenterol. 2014;20(44):16409–17.Google Scholar
Laverdure, N, Scholtes-Brunel, C, Rivet, C, Heissat, S, Restier, L, Bacchetta, J, et al. Paediatric Liver Transplanted Patients and Prevalence of Hepatitis E Virus. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2015;69:22–6.Google Scholar
Eisenbach, C, Longerich, T, Fickenscher, H, Schalasta, G, Stremmel, W, Encke, J. Recurrence of Clinically Significant Hepatitis A Following Liver Transplantation for Fulminant Hepatitis A. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2006;35(1):109–12.Google Scholar
Park, GC, Hwang, S, Yu, YD, Park, PJ, Choi, YI, Song, GW, et al. Intractable Recurrent Hepatitis A Virus Infection Requiring Repeated Liver Transplantation: A Case Report. Transplantation Proceedings. 2010;42(10):4658–60.Google Scholar
Gane, E, Sallie, R, Saleh, M, Portmann, B, Williams, R. Clinical Recurrence of Hepatitis A Following Liver Transplantation for Acute Liver Failure. J Med Virol. 1995;45(1):35–9.Google Scholar
Fagan, E, Yousef, G, Brahm, J, Garelick, H, Mann, G, Wolstenholme, A, et al. Persistence of Hepatitis A Virus in Fulminant Hepatitis and after Liver Transplantation. J Med Virol. 1990;30(2):131–6.Google Scholar
Liu, J, Zhang, S, Wang, Q, Shen, H, Zhang, M, Zhang, Y, et al. Seroepidemiology of Hepatitis B Virus Infection in 2 Million Men Aged 21–49 Years in Rural China: A Population-based, Cross-sectional Study. The Lancet Infectious Diseases. 2015.Google Scholar
Zhang, W, Ji, Z, Wang, L, Xiao, D, Yan, Y. A Meta-analysis of HBsAg-positive Rate among General Chinese Populations Aged 1–59 Years. Infectious Diseases (London, England). 2015:1–11.Google Scholar
Samuel, D, Muller, R, Alexander, G, Fassati, L, Ducot, B, Benhamou, JP, et al. Liver Transplantation in European Patients with the Hepatitis B Surface Antigen. The New England Journal of Medicine. 1993;329(25):1842–7.Google Scholar
Jiang, L, Yan, LN. Current Therapeutic Strategies for Recurrent Hepatitis B Virus Infection after Liver Transplantation. World Journal of Gastroenterology: WJG. 2010;16(20):2468–75.Google Scholar
Chen, J, Yi, L, Jia, JD, Ma, H, You, H. Hepatitis B Immunoglobulins and/or Lamivudine for Preventing Hepatitis B Recurrence after Liver Transplantation: A Systematic Review. J Gastroenterol Hepatol. 2010;25(5):872–9.Google Scholar
Fung, J, Lo, R, Chan, SC, Chok, K, Wong, T, Sharr, W, et al. Outcomes Including Liver Histology after Liver Transplantation for Chronic Hepatitis B Using Oral Antiviral Therapy Alone. Liver Transpl. 2015.Google Scholar
Wesdorp, DJ, Knoester, M, Braat, AE, Coenraad, MJ, Vossen, AC, Claas, EC, et al. Nucleoside Plus Nucleotide Analogs and Cessation of Hepatitis B Immunoglobulin after Liver Transplantation in Chronic Hepatitis B Is Safe and Effective. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2013;58(1):6773.Google Scholar
Yurdaydin, C, Idilman, R. Therapy of Delta Hepatitis. Cold Spring Harbor Perspectives in Medicine. 2015.Google Scholar
Pascarella, S, Negro, F. Hepatitis D Virus: An Update. Liver International: Official Journal of the International Association for the Study of the Liver. 2011;31(1):721.Google Scholar
Govindarajan, S, De Cock, KM, Redeker, AG. Natural Course of Delta Superinfection in Chronic Hepatitis B Virus-infected Patients: Histopathologic Study with Multiple Liver Biopsies. Hepatology. 1986;6(4):640–4.Google Scholar
Roche, B, Samuel, D. Liver Transplantation in Delta Virus Infection. Seminars in Liver Disease. 2012;32(3):245–55.Google Scholar
Demetris, AJ, Jaffe, R, Sheahan, DG, Burnham, J, Spero, J, Iwatsuki, S, et al. Recurrent Hepatitis B in Liver Allograft Recipients. Differentiation between Viral Hepatitis B and Rejection. Am J Pathol. 1986;125(1):161–72.Google Scholar
Demetris, AJ, Todo, S, Van Thiel, DH, Fung, JJ, Iwaki, Y, Sysyn, G, et al. Evolution of Hepatitis B Virus Liver Disease after Hepatic Replacement. Practical and Theoretical Considerations. Am J Pathol. 1990;137(3):667–76.Google Scholar
Zhang, X, Xiang, C, Zhou, YH, Jiang, A, Qin, YY, He, J. Effect of Statins on Cardiovascular Events in Patients with Mild to Moderate Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials. BMC Cardiovasc Disord. 2014;14:19.Google Scholar
Roche, B, Samuel, D. The Difficulties of Managing Severe Hepatitis B Virus Reactivation. Liver International: Official Journal of the International Association for the Study of the Liver. 2011;31 Suppl 1:104–10.Google Scholar
Harrison, RF, Davies, MH, Goldin, RD, Hubscher, SG. Recurrent Hepatitis B in Liver Allografts: A Distinctive Form of Rapidly Developing Cirrhosis. Histopathology. 1993;23(1):21–8.Google Scholar
Thung, SN. Histologic Findings in Recurrent HBV. Liver Transpl. 2006;12(11 Suppl 2):S503.Google Scholar
Davies, SE, Portmann, BC, O’Grady, JG, Aldis, PM, Chaggar, K, Alexander, GJ, et al. Hepatic Histological Findings after Transplantation for Chronic Hepatitis B Virus Infection, Including a Unique Pattern of Fibrosing Cholestatic Hepatitis. Hepatology. 1991;13(1):150–7.Google Scholar
O’Grady, JG, Smith, HM, Davies, SE, Daniels, HM, Donaldson, PT, Tan, KC, et al. Hepatitis B Virus Reinfection after Orthotopic Liver Transplantation. Serological and Clinical Implications. Journal of Hepatology. 1992;14(1):104–11.Google Scholar
Yurdaydin, C, Idilman, R, Bozkaya, H, Bozdayi, AM. Natural History and Treatment of Chronic Delta Hepatitis. J Viral Hepat. 2010;17(11):749–56.Google Scholar
Salomao, M, Verna, EC, Lefkowitch, JH, Moreira, RK. Histopathologic Distinction between Fibrosing Cholestatic Hepatitis C and Biliary Obstruction. The American Journal of Surgical Pathology. 2013;37(12):1837–44.Google Scholar
Verna, EC. Hepatitis Viruses and Liver Transplantation: Evolving Trends in Antiviral Management. Clin Liver Dis. 2014;18(3):575601.Google Scholar
Verna, EC, O’Leary, JG. Hepatitis C Treatment in Patients on the Liver Transplant Waiting List. Curr Opin Organ Transplant. 2015;20(3):242–50.Google Scholar
Gane, EJ. The Natural History of Recurrent Hepatitis C and What Influences This. Liver Transpl. 2008;14 Suppl 2:S3644.Google Scholar
Ramirez, S, Perez-Del-Pulgar, S, Forns, X. Virology and Pathogenesis of Hepatitis C Virus Recurrence. Liver Transpl. 2008;14 Suppl 2:S2735.Google Scholar
McCaughan, GW, Shackel, NA, Bertolino, P, Bowen, DG. Molecular and Cellular Aspects of Hepatitis C Virus Reinfection after Liver Transplantation: How the Early Phase Impacts on Outcomes. Transplantation. 2009;87(8):1105–11.Google Scholar
Verna, EC, Abdelmessih, R, Salomao, MA, Lefkowitch, J, Moreira, RK, Brown, RS Jr. Cholestatic Hepatitis C Following Liver Transplantation: An Outcome-based Histological Definition, Clinical Predictors, and Prognosis. Liver Transpl. 2013;19(1):7888.Google Scholar
Berenguer, M, Aguilera, V, Prieto, M, San Juan, F, Rayon, JM, Benlloch, S, et al. Significant Improvement in the Outcome of HCV-infected Transplant Recipients by Avoiding Rapid Steroid Tapering and Potent Induction Immunosuppression. Journal of Hepatology. 2006;44(4):717–22.Google Scholar
Marcos, A, Eghtesad, B, Fung, JJ, Fontes, P, Patel, K, Devera, M, et al. Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus. Transplantation. 2004;78(7):966–71.Google Scholar
Eghtesad, B, Fung, JJ, Demetris, AJ, Murase, N, Ness, R, Bass, DC, et al. Immunosuppression for Liver Transplantation in HCV-infected Patients: Mechanism-based Principles. Liver Transpl. 2005;11(11):1343–52.Google Scholar
Thursz, M, Yee, L, Khakoo, S. Understanding the Host Genetics of Chronic Hepatitis B and C. Seminars in Liver Disease. 2011;31(2):115–27.Google Scholar
Charlton, MR, Thompson, A, Veldt, BJ, Watt, K, Tillmann, H, Poterucha, JJ, et al. Interleukin-28B Polymorphisms Are Associated with Histological Recurrence and Treatment Response Following Liver Transplantation in Patients with Hepatitis C Virus Infection. Hepatology. 2011;53(1):317–24.Google Scholar
Fukuhara, T, Taketomi, A, Motomura, T, Okano, S, Ninomiya, A, Abe, T, et al. Variants in IL28B in Liver Recipients and Donors Correlate with Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C. Gastroenterology. 2010;139(5):1577–85, 85 e1–3.Google Scholar
Demetris, AJ. Evolution of Hepatitis C Virus in Liver Allografts. Liver Transpl. 2009;15 Suppl 2:S3541.Google Scholar
Chhatwal, J, Kanwal, F, Roberts, MS, Dunn, MA. Cost-effectiveness and Budget Impact of Hepatitis C Virus Treatment with Sofosbuvir and Ledipasvir in the United States. Ann Intern Med. 2015;162(6):397406.Google Scholar
Berenguer, M. Natural History of Recurrent Hepatitis C. Liver Transpl. 2002;8(10 Suppl 1):S148.Google Scholar
Berenguer, M, Aguilera, V, Prieto, M, Carrasco, D, Rayon, M, San Juan, F, et al. Delayed Onset of Severe Hepatitis C-related Liver Damage Following Liver Transplantation: A Matter of Concern? Liver Transpl. 2003;9(11):1152–8.Google Scholar
Dhanasekaran, R, Sanchez, W, Mounajjed, T, Wiesner, RH, Watt, KD, Charlton, MR. Impact of Fibrosis Progression on Clinical Outcome in Patients Treated for Post-transplant Hepatitis C Recurrence. Liver International: Official Journal of the International Association for the Study of the Liver. 2015.Google Scholar
Burton, JR Jr., Rosen, HR. Acute Rejection in HCV-infected Liver Transplant Recipients: The Great Conundrum. Liver Transpl. 2006;12(11 Suppl 2):S3847.Google Scholar
Moreira, RK. Recurrent Hepatitis C and Acute Allograft Rejection: Clinicopathologic Features with Emphasis on the Differential Diagnosis between These Entities. Advances in Anatomic Pathology. 2011;18(5):393405.Google Scholar
Asanza, CG, Garcia-Monzon, C, Clemente, G, Salcedo, M, Garcia-Buey, L, Garcia-Iglesias, C, et al. Immunohistochemical Evidence of Immunopathogenetic Mechanisms in Chronic Hepatitis C Recurrence after Liver Transplantation. Hepatology. 1997;26(3):755–63.Google Scholar
Rosen, HR, Martin, P. Hepatitis, C Infection in Patients Undergoing Liver Retransplantation. Transplantation. 1998;66(12):1612–6.Google Scholar
Rosen, HR, Martin, P, Goss, J, Donovan, J, Melinek, J, Rudich, S, et al. Significance of Early Aminotransferase Elevation after Liver Transplantation. Transplantation. 1998;65(1):6872.Google Scholar
Ferrell, LD, Wright, TL, Roberts, J, Ascher, N, Lake, J. Hepatitis C Viral Infection in Liver Transplant Recipients. Hepatology. 1992;16(4):865–76.Google Scholar
Demetris, AJ, Sebagh, M. Plasma Cell Hepatitis in Liver Allografts: Variant of Rejection or Autoimmune Hepatitis? Liver Transpl. 2008;14(6):750–5.Google Scholar
Guido, M, Burra, P. De Novo Autoimmune Hepatitis after Liver Transplantation. Seminars in Liver Disease. 2011;31(1):7181.Google Scholar
Castillo-Rama, M, Sebagh, M, Sasatomi, E, Randhawa, P, Isse, K, Salgarkar, AD, et al. “Plasma Cell Hepatitis” in Liver Allografts: Identification and Characterization of an IgG4-Rich Cohort. Am J Transplant. 2013;13(11):2966–77.Google Scholar
Fiel, MI, Agarwal, K, Stanca, C, Elhajj, N, Kontorinis, N, Thung, SN, et al. Posttransplant Plasma Cell Hepatitis (de Novo Autoimmune Hepatitis) Is a Variant of Rejection and May Lead to a Negative Outcome in Patients with Hepatitis C Virus. Liver Transpl. 2008;14(6):861–71.Google Scholar
Berardi, S, Lodato, F, Gramenzi, A, D’Errico, A, Lenzi, M, Bontadini, A, et al. High Incidence of Allograft Dysfunction in Liver Transplanted Patients Treated with Pegylated-interferon Alpha-2b and Ribavirin for Hepatitis C Recurrence: Possible de Novo Autoimmune Hepatitis? Gut. 2007;56(2):237–42.Google Scholar
Alvarez, F, Berg, PA, Bianchi, FB, Bianchi, L, Burroughs, AK, Cancado, EL, et al. International Autoimmune Hepatitis Group Report: Review of Criteria for Diagnosis of Autoimmune Hepatitis. Journal of Hepatology. 1999;31(5):929–38.Google Scholar
Czaja, AJ, Carpenter, HA. Sensitivity, Specificity, and Predictability of Biopsy Interpretations in Chronic Hepatitis. Gastroenterology. 1993;105(6):1824–32.Google Scholar
Czaja, AJ, Carpenter, HA. Histological Findings in Chronic Hepatitis C with Autoimmune Features. Hepatology. 1997;26(2):459–66.Google Scholar
Khettry, U, Huang, WY, Simpson, MA, Pomfret, EA, Pomposelli, JJ, Lewis, WD, et al. Patterns of Recurrent Hepatitis C after Liver Transplantation in a Recent Cohort of Patients. Hum Pathol. 2007;38(3):443–52.Google Scholar
Kessel, A, Toubi, E. Chronic HCV-related Autoimmunity: A Consequence of Viral Persistence and Lymphotropism. Current Medicinal Chemistry. 2007;14(5):547–54.Google Scholar
Schiano, TD, Te, HS, Thomas, RM, Hussain, H, Bond, K, Black, M. Results of Steroid-based Therapy for the Hepatitis C-autoimmune Hepatitis Overlap Syndrome. The American Journal of Gastroenterology. 2001;96(10):2984–91.Google Scholar
Zekry, A, Bishop, GA, Bowen, DG, Gleeson, MM, Guney, S, Painter, DM, et al. Intrahepatic Cytokine Profiles Associated with Posttransplantation Hepatitis C Virus-related Liver Injury. Liver Transpl. 2002;8(3):292301.Google Scholar
Narang, TK, Ahrens, W, Russo, MW. Post-liver Transplant Cholestatic Hepatitis C: A Systematic Review of Clinical and Pathological Findings and Application of Consensus Criteria. Liver Transpl. 2010;16(11):1228–35.Google Scholar
Leroy, V, Dumortier, J, Coilly, A, Sebagh, M, Fougerou-Leurent, C, Radenne, S, et al. Efficacy of Sofosbuvir and Daclatasvir in Patients with Fibrosing Cholestatic Hepatitis C after Liver Transplantation. Clin Gastroenterol Hepatol. 2015.Google Scholar
Selzner, N, Guindi, M, Renner, EL, Berenguer, M. Immune-mediated Complications of the Graft in Interferon-treated Hepatitis C Positive Liver Transplant Recipients. Journal of Hepatology. 2011;55(1):207–17.Google Scholar
Wiesner, RH, Demetris, AJ, Belle, SH, Seaberg, EC, Lake, JR, Zetterman, RK, et al. Acute Hepatic Allograft Rejection: Incidence, Risk Factors, and Impact on Outcome. Hepatology. 1998;28(3):638–45.Google Scholar
Pischke, S, Suneetha, PV, Baechlein, C, Barg-Hock, H, Heim, A, Kamar, N, et al. Hepatitis E Virus Infection as a Cause of Graft Hepatitis in Liver Transplant Recipients. Liver Transpl. 2010;16(1):7482.Google Scholar
Pischke, S, Wedemeyer, H. Chronic Hepatitis E in Liver Transplant Recipients: A Significant Clinical Problem? Minerva Gastroenterol Dietol. 2010;56(2):121–8.Google Scholar
Kamar, N, Garrouste, C, Haagsma, EB, Garrigue, V, Pischke, S, Chauvet, C, et al. Factors Associated with Chronic Hepatitis in Patients with Hepatitis E Virus Infection Who Have Received Solid Organ Transplants. Gastroenterology. 2011;140(5):1481–9.Google Scholar
Haagsma, EB, Riezebos-Brilman, A, van den Berg, AP, Porte, RJ, Niesters, HG. Treatment of Chronic Hepatitis E in Liver Transplant Recipients with Pegylated Interferon Alpha-2b. Liver Transpl. 2010;16(4):474–7.Google Scholar
Kamar, N, Abravanel, F, Selves, J, Garrouste, C, Esposito, L, Lavayssiere, L, et al. Influence of Immunosuppressive Therapy on the Natural History of Genotype 3 Hepatitis-E Virus Infection after Organ Transplantation. Transplantation. 2010;89(3):353–60.Google Scholar
Haagsma, EB, Niesters, HG, van den Berg, AP, Riezebos-Brilman, A, Porte, RJ, Vennema, H, et al. Prevalence of Hepatitis E Virus Infection in Liver Transplant Recipients. Liver Transpl. 2009;15(10):1225–8.Google Scholar
Kamar, N, Selves, J, Mansuy, JM, Ouezzani, L, Peron, JM, Guitard, J, et al. Hepatitis E Virus and Chronic Hepatitis in Organ-transplant Recipients. N Engl J Med. 2008;358(8):811–7.Google Scholar
Aggarwal, R, Jameel, S. Hepatitis E. Hepatology. 2011;54(6):2218–26.Google Scholar
Behrendt, P, Steinmann, E, Manns, MP, Wedemeyer, H. The Impact of Hepatitis E in the Liver Transplant Setting. Journal of Hepatology. 2014;61(6):1418–29.Google Scholar
Halac, U, Beland, K, Lapierre, P, Patey, N, Ward, P, Brassard, J, et al. Chronic Hepatitis E Infection in Children with Liver Transplantation. Gut. 2011.Google Scholar
Peters van Ton, AM, Gevers, TJ, Drenth, JP. Antiviral Therapy in Chronic Hepatitis E: A Systematic Review. J Viral Hepat. 2015.Google Scholar
Abravanel, F, Lhomme, S, Chapuy-Regaud, S, Peron, JM, Alric, L, Rostaing, L, et al. Performance of a New Rapid Test for Detecting Anti-hepatitis E Virus Immunoglobulin M in Immunocompetent and Immunocompromised Patients. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2015;70:101–4.Google Scholar
Raczyńska, J, Habior, A, Pączek, L, Foroncewicz, B, Pawełas, A, Mucha, K. Primary Biliary Cirrhosis in the Era of Liver Transplantation. Ann Transplant. 2014;19:488–93.Google Scholar
Gautam, M, Cheruvattath, R, Balan, V. Recurrence of Autoimmune Liver Disease after Liver Transplantation: A Systematic Review. Liver Transpl. 2006;12(12):1813–24.Google Scholar
Liaskou, E, Henriksen, EK, Holm, K, Kaveh, F, Hamm, D, Fear, J, et al. High-throughput T-cell Receptor Sequencing across Chronic Liver Diseases Reveals Distinct Disease-associated Repertoires. Hepatology. 2015.Google Scholar
Mendes, F, Couto, CA, Levy, C. Recurrent and de Novo Autoimmune Liver Diseases. Clinics in Liver Disease. 2011;15(4):859–78.Google Scholar
Czaja, AJ, Manns, MP. Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology. 2010;139(1):5872 e4.Google Scholar
Venick, RS, McDiarmid, SV, Farmer, DG, Gornbein, J, Martin, MG, Vargas, JH, et al. Rejection and Steroid Dependence: Unique Risk Factors in the Development of Pediatric Posttransplant de Novo Autoimmune Hepatitis. Am J Transplant. 2007;7(4):955–63.Google Scholar
Inui, A, Sogo, T, Komatsu, H, Miyakawa, H, Fujisawa, T. Antibodies against Cytokeratin 8/18 in a Patient with de Novo Autoimmune Hepatitis after Living-donor Liver Transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2005;11(5):504–7.Google Scholar
Huguet, S, Vinh, J, Johanet, C, Samuel, D, Gigou, M, Zamfir, O, et al. Identification by Proteomic Tool of Atypical Anti-liver/Kidney Microsome Autoantibodies Targets in de Novo Autoimmune Hepatitis after Liver Transplantation. Ann N Y Acad Sci. 2007;1109:345–57.Google Scholar
Yamagiwa, S, Kamimura, H, Takamura, M, Genda, T, Ichida, T, Nomoto, M, et al. Presence of Antibodies against Self Human Leukocyte Antigen Class II Molecules in Autoimmune Hepatitis. International Journal of Medical Sciences. 2014;11(9):850–6.Google Scholar
Maggiore, G, Gonzales, E, Sciveres, M, Redon, MJ, Grosse, B, Stieger, B, et al. Relapsing Features of Bile Salt Export Pump Deficiency after Liver Transplantation in Two Patients with Progressive Familial Intrahepatic Cholestasis Type 2. Journal of Hepatology. 2010;53(5):981–6.Google Scholar
Jara, P, Hierro, L, Martinez-Fernandez, P, Alvarez-Doforno, R, Yanez, F, Diaz, MC, et al. Recurrence of Bile Salt Export Pump Deficiency after Liver Transplantation. The New England Journal of Medicine. 2009;361(14):1359–67.Google Scholar
Siebold, L, Dick, AA, Thompson, R, Maggiore, G, Jacquemin, E, Jaffe, R, et al. Recurrent Low Gamma-glutamyl Transpeptidase Cholestasis Following Liver Transplantation for Bile Salt Export Pump (BSEP) Disease (Posttransplant Recurrent BSEP Disease). Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2010;16(7):856–63.Google Scholar
Sebagh, M, Castillo-Rama, M, Azoulay, D, Coilly, A, Delvart, V, Allard, MA, et al. Histologic Findings Predictive of a Diagnosis of de Novo Autoimmune Hepatitis after Liver Transplantation in Adults. Transplantation. 2013;96(7):670–8.Google Scholar
Abraham, SC, Freese, DK, Ishitani, MB, Krasinskas, AM, Wu, TT. Significance of Central Perivenulitis in Pediatric Liver Transplantation. The American Journal of Surgical Pathology. 2008;32(10):1479–88.Google Scholar
Poupon, R. Primary Biliary Cirrhosis: A 2010 Update. Journal of Hepatology. 2010;52(5):745–58.Google Scholar
Silveira, MG, Talwalkar, JA, Lindor, KD, Wiesner, RH. Recurrent Primary Biliary Cirrhosis after Liver Transplantation. Am J Transplant. 2010;10(4):720–6.Google Scholar
Bosch, A, Dumortier, J, Maucort-Boulch, D, Scoazec, JY, Wendum, D, Conti, F, et al. Preventive Administration of UDCA after Liver Transplantation for Primary Biliary Cirrhosis Is Associated with a Lower Risk of Disease Recurrence. Journal of Hepatology. 2015.Google Scholar
Sebagh, M, Farges, O, Dubel, L, Samuel, D, Bismuth, H, Reynes, M. Histological Features Predictive of Recurrence of Primary Biliary Cirrhosis after Liver Transplantation. Transplantation. 1998;65(10):1328–33.Google Scholar
Hubscher, SG, Elias, E, Buckels, JA, Mayer, AD, McMaster, P, Neuberger, JM. Primary Biliary Cirrhosis. Histological Evidence of Disease Recurrence after Liver Transplantation. Journal of Hepatology. 1993;18(2):173–84.Google Scholar
Jones, DE, James, OF, Portmann, B, Burt, AD, Williams, R, Hudson, M. Development of Autoimmune Hepatitis Following Liver Transplantation for Primary Biliary Cirrhosis. Hepatology. 1999;30(1):53–7.Google Scholar
Graziadei, IW. Recurrence of Nonviral Liver Diseases after Liver Transplantation. Clin Liver Dis. 2014;18(3):675–85.Google Scholar
Demetris, AJ, Markus, BH, Esquivel, C, Van Thiel, DH, Saidman, S, Gordon, R, et al. Pathologic Analysis of Liver Transplantation for Primary Biliary Cirrhosis. Hepatology. 1988;8(4):939–47.Google Scholar
Kang, YZ, Sun, XY, Liu, YH, Shen, ZY. Autoimmune Hepatitis-primary Biliary Cirrhosis Concurrent with Biliary Stricture after Liver Transplantation. World J Gastroenterol. 2015;21(7):2236–41.Google Scholar
Bhanji, RA, Mason, AL, Girgis, S, Montano-Loza, AJ. Liver Transplantation for Overlap Syndromes of Autoimmune Liver Diseases. Liver International: Official Journal of the International Association for the Study of the Liver. 2013;33(2):210–9.Google Scholar
Li, Y, Ayata, G, Baker, SP, Banner, BF. Cholangitis: A Histologic Classification Based on Patterns of Injury in Liver Biopsies. Pathol Res Pract. 2005;201(8–9):565–72.Google Scholar
Vakiani, E, Hunt, KK, Mazziotta, RM, Emond, JC, Brown, RS, Lefkowitch, JH, et al. Hepatitis C-associated Granulomas after Liver Transplantation: Morphologic Spectrum and Clinical Implications. American Journal of Clinical Pathology. 2007;127(1):128–34.Google Scholar
Fosby, B, Karlsen, TH, Melum, E. Recurrence and Rejection in Liver Transplantation for Primary Sclerosing Cholangitis. World Journal of Gastroenterology: WJG. 2012;18(1):115.Google Scholar
Ravikumar, R, Tsochatzis, E, Jose, S, Allison, M, Athale, A, Creamer, F, et al. Risk Factors for Recurrent Primary Sclerosing Cholangitis after Liver Transplantation. Journal of Hepatology. 2015.Google Scholar
Gelley, F, Zadori, G, Gorog, D, Kobori, L, Fehervari, I, Gaman, G, et al. Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation – The Hungarian Experience. Interventional Medicine & Applied Science. 2014;6(1):16–8.Google Scholar
Sheng, R, Campbell, WL, Zajko, AB, Baron, RL. Cholangiographic Features of Biliary Strictures after Liver Transplantation for Primary Sclerosing Cholangitis: Evidence of Recurrent Disease. AJR Am J Roentgenol. 1996;166(5):1109–13.Google Scholar
Rai, RM, Boitnott, J, Klein, AS, Thuluvath, PJ. Features of Recurrent Primary Sclerosing Cholangitis in Two Consecutive Liver Allografts after Liver Transplantation. Journal of Clinical Gastroenterology. 2001;32(2):151–4.Google Scholar
Jeyarajah, DR, Netto, GJ, Lee, SP, Testa, G, Abbasoglu, O, Husberg, BS, et al. Recurrent Primary Sclerosing Cholangitis after Orthotopic Liver Transplantation: Is Chronic Rejection Part of the Disease Process? Transplantation. 1998;66(10):1300–6.Google Scholar
Carrasco-Avino, G, Schiano, TD, Ward, SC, Thung, SN, Fiel, MI. Primary Sclerosing Cholangitis: Detailed Histologic Assessment and Integration Using Bioinformatics Highlights Arterial Fibrointimal Hyperplasia as a Novel Feature. Am J Clin Pathol. 2015;143(4):505–13.Google Scholar
Jaffe, R. Liver Transplant Pathology in Pediatric Metabolic Disorders. Pediatr Dev Pathol. 1998;1(2):102–17.Google Scholar
Hansen, K, Horslen, S. Metabolic Liver Disease in Children. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2008;14(5):713–33.Google Scholar
Zezos, P, Renner, EL. Liver Transplantation and Non-alcoholic Fatty Liver Disease. World J Gastroenterol. 2014;20(42):15532–8.Google Scholar
Merola, J, Liapakis, A, Mulligan, DC, Yoo, PS. Non-alcoholic Fatty Liver Disease Following Liver Transplantation: A Clinical Review. Clin Transplant. 2015;29(9):728–37.Google Scholar
Charlton, MR, Burns, JM, Pedersen, RA, Watt, KD, Heimbach, JK, Dierkhising, RA. Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States. Gastroenterology. 2011;141(4):1249–53.Google Scholar
Ong, J, Younossi, ZM, Reddy, V, Price, LL, Gramlich, T, Mayes, J, et al. Cryptogenic Cirrhosis and Posttransplantation Nonalcoholic Fatty Liver Disease. Liver Transpl. 2001;7(9):797801.Google Scholar
Patil, DT, Yerian, LM. Evolution of Nonalcoholic Fatty Liver Disease Recurrence after Liver Transplantation. Liver Transpl. 2012;18(10):1147–53.Google Scholar
Hanouneh, IA, Macaron, C, Lopez, R, Feldstein, AE, Yerian, L, Eghtesad, B, et al. Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus Infection. International Journal of Organ Transplantation Medicine. 2011;2(2):5765.Google Scholar
Tevar, AD, Clarke, C, Wang, J, Rudich, SM, Woodle, ES, Lentsch, AB, et al. Clinical Review of Nonalcoholic Steatohepatitis in Liver Surgery and Transplantation. Journal of the American College of Surgeons. 2010;210(4):515–26.Google Scholar
Contos, MJ, Cales, W, Sterling, RK, Luketic, VA, Shiffman, ML, Mills, AS, et al. Development of Nonalcoholic Fatty Liver Disease after Orthotopic Liver Transplantation for Cryptogenic Cirrhosis. Liver Transpl. 2001;7(4):363–73.Google Scholar
Dumortier, J, Giostra, E, Belbouab, S, Morard, I, Guillaud, O, Spahr, L, et al. Non-alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil.” The American Journal of Gastroenterology. 2010;105(3):613–20.Google Scholar
Malik, SM, Ahmad, J. Outcomes of Liver Transplantation in Patients with Cirrhosis due to Nonalcoholic Steatohepatitis versus Patients with Cirrhosis due to Alcoholic Liver Disease. Liver Transpl. 2010;16(4):533.Google Scholar
Malik, SM, Devera, ME, Fontes, P, Shaikh, O, Sasatomi, E, Ahmad, J. Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis. Liver Transpl. 2009;15(12):1843–51.Google Scholar
Malik, SM, deVera, ME, Fontes, P, Shaikh, O, Ahmad, J. Outcome after Liver Transplantation for NASH Cirrhosis. Am J Transplant. 2009;9(4):782–93.Google Scholar
Ayata, G, Gordon, FD, Lewis, WD, Pomfret, E, Pomposelli, JJ, Jenkins, RL, et al. Cryptogenic Cirrhosis: Clinicopathologic Findings at and after Liver Transplantation. Hum Pathol. 2002;33(11):1098–104.Google Scholar
Kim, WR, Poterucha, JJ, Porayko, MK, Dickson, ER, Steers, JL, Wiesner, RH. Recurrence of Nonalcoholic Steatohepatitis Following Liver Transplantation. Transplantation. 1996;62(12):1802–5.Google Scholar
Takata, MC, Campos, GM, Ciovica, R, Rabl, C, Rogers, SJ, Cello, JP, et al. Laparoscopic Bariatric Surgery Improves Candidacy in Morbidly Obese Patients Awaiting Transplantation. Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery. 2008;4(2):159–64; discussion 64–5.Google Scholar
Marszalek, R, Ziemianski, P, Lagiewska, B, Pacholczyk, M, Domienik-Karlowicz, J, Trzebicki, J, et al. The First Polish Liver Transplantation after Roux-en-Y Gastric Bypass Surgery for Morbid Obesity: A Case Report and Literature Review. Ann Transplant. 2015;20:112–5.Google Scholar
Brunt, EM, Tiniakos, DG. Histopathology of Nonalcoholic Fatty Liver Disease. World J Gastroenterol. 2010;16(42):5286–96.Google Scholar
Lucey, MR. Liver Transplantation in Patients with Alcoholic Liver Disease. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(7):751–9.Google Scholar
Bellamy, CO, DiMartini, AM, Ruppert, K, Jain, A, Dodson, F, Torbenson, M, et al. Liver Transplantation for Alcoholic Cirrhosis: Long Term Follow-up and Impact of Disease Recurrence. Transplantation. 2001;72(4):619–26.Google Scholar
Jimenez-Romero, C, Justo-Alonso, I, Cambra-Molero, F, Calvo-Pulido, J, Garcia-Sesma, A, Abradelo-Usera, M, et al. Incidence, Risk Factors and Outcome of de Novo Tumors in Liver Transplant Recipients Focusing on Alcoholic Cirrhosis. World J Hepatol. 2015;7(7):942–53.Google Scholar
Abosh, D, Rosser, B, Kaita, K, Bazylewski, R, Minuk, G. Outcomes Following Liver Transplantation for Patients with Alcohol- versus Nonalcohol-induced Liver Disease. Can J Gastroenterol. 2000;14(10):851–5.Google Scholar
Conjeevaram, HS, Hart, J, Lissoos, TW, Schiano, TD, Dasgupta, K, Befeler, AS, et al. Rapidly Progressive Liver Injury and Fatal Alcoholic Hepatitis Occurring after Liver Transplantation in Alcoholic Patients. Transplantation. 1999;67(12):1562–8.Google Scholar
Molloy, RM, Komorowski, R, Varma, RR. Recurrent Nonalcoholic Steatohepatitis and Cirrhosis after Liver Transplantation. Liver Transpl Surg. 1997;3(2):177–8.Google Scholar
Tang, H, Boulton, R, Gunson, B, Hubscher, S, Neuberger, J. Patterns of Alcohol Consumption after Liver Transplantation. Gut. 1998;43(1):140–5.Google Scholar
Schieber, K, Lindner, M, Sowa, JP, Gerken, G, Scherbaum, N, Kahraman, A, et al. Self-reports on Symptoms of Alcohol Abuse: Liver Transplant Patients versus Rehabilitation Therapy Patients. Progress in Transplantation (Aliso Viejo, Calif). 2015;25(3):203–9.Google Scholar
Rice, JP, Eickhoff, J, Agni, R, Ghufran, A, Brahmbhatt, R, Lucey, MR. Abusive Drinking after Liver Transplantation Is Associated with Allograft Loss and Advanced Allograft Fibrosis. Liver Transpl. 2013;19(12):1377–86.Google Scholar
MacSween, RN, Burt, AD. Histologic Spectrum of Alcoholic Liver Disease. Seminars in Liver Disease. 1986;6(3):221–32.Google Scholar
Saragoca, A, Moreira, ML, Novais, L, Vilar, D, Silva, HS, Baptista, AS. Liver Injury in Chronic Alcoholism: Clinical, Laboratorial and Histological Correlation. Acta medica portuguesa. 1981(Suppl 2):6574.Google Scholar
Pageaux, GP, Bismuth, M, Perney, P, Costes, V, Jaber, S, Possoz, P, et al. Alcohol Relapse after Liver Transplantation for Alcoholic Liver Disease: Does It Matter? Journal of Hepatology. 2003;38(5):629–34.Google Scholar
Hubscher, SG. Recurrent Autoimmune Hepatitis after Liver Transplantation: Diagnostic Criteria, Risk Factors, and Outcome. Liver Transpl. 2001;7(4):285–91.Google Scholar
Kaneku, H, O’Leary, JG, Taniguchi, M, Susskind, BM, Terasaki, PI, Klintmalm, GB. Donor-specific Human Leukocyte Antigen Antibodies of the Immunoglobulin G3 Subclass Are Associated with Chronic Rejection and Graft Loss after Liver Transplantation. Liver Transpl. 2012;18(8):984–92.Google Scholar
Shaikh, OS, Demetris, AJ. Idiopathic Posttransplantation Hepatitis? Liver Transpl. 2007;13(7):943–6.Google Scholar
Aini, W, Miyagawa-Hayashino, A, Tsuruyama, T, Hashimoto, S, Sumiyoshi, S, Ozeki, M, et al. Telomere Shortening and Karyotypic Alterations in Hepatocytes in Long-term Transplanted Human Liver Allografts. Transpl Int. 2012;25(9):956–66.Google Scholar
Adeyi, O, Fischer, SE, Guindi, M. Liver Allograft Pathology: Approach to Interpretation of Needle Biopsies with Clinicopathological Correlation. J Clin Pathol. 2010;63(1):4774.Google Scholar
Gane, E, Portmann, B, Saxena, R, Wong, P, Ramage, J, Williams, R. Nodular Regenerative Hyperplasia of the Liver Graft after Liver Transplantation. Hepatology. 1994;20(1 Pt 1):8894.Google Scholar
Devarbhavi, H, Abraham, S, Kamath, PS. Significance of Nodular Regenerative Hyperplasia Occurring de Novo Following Liver Transplantation. Liver Transpl. 2007;13(11):1552–6.Google Scholar
Eguchi, S, Takatsuki, M, Hidaka, M, Soyama, A, Muraoka, I, Tomonaga, T, et al. Lack of Grafted Liver Rejuvenation in Adult-to-Pediatric Liver Transplantation. Digestive Diseases and Sciences. 2011;56(5):1542–7.Google Scholar
Espinasse, G, Kamar, N, Hurault, C, Suc, B, Fourtanier, G, Montastruc, JL, et al. Drug Exposure and Perceived Adverse Drug Events Reported by Liver-transplant Patients. Int J Clin Pharmacol Ther. 2009;47(3):159–64.Google Scholar
Sterneck, M, Wiesner, R, Ascher, N, Roberts, J, Ferrell, L, Ludwig, J, et al. Azathioprine Hepatotoxicity after Liver Transplantation. Hepatology. 1991;14(5):806–10.Google Scholar
Lefkowitch, JH, Lobritto, SJ, Brown, RS Jr., Emond, JC, Schilsky, ML, Rosenthal, LA, et al. Ground-glass, Polyglucosan-like Hepatocellular Inclusions: A “New” Diagnostic Entity. Gastroenterology. 2006;131(3):713–8.Google Scholar
Mells, G, Mann, C, Hubscher, S, Neuberger, J. Late Protocol Liver Biopsies in the Liver Allograft: A Neglected Investigation? Liver Transpl. 2009;15(8):931–8.Google Scholar
Abraham, SC, Poterucha, JJ, Rosen, CB, Demetris, AJ, Krasinskas, AM. Histologic Abnormalities Are Common in Protocol Liver Allograft Biopsies from Patients with Normal Liver Function Tests. The American Journal of Surgical Pathology. 2008;32(7):965–73.Google Scholar
Mells, G, Neuberger, J. Protocol Liver Allograft Biopsies. Transplantation. 2008;85(12):1686–92.Google Scholar
Ahmad, W, Ijaz, B, Gull, S, Asad, S, Khaliq, S, Jahan, S, et al. A Brief Review on Molecular, Genetic and Imaging Techniques for HCV Fibrosis Evaluation. Virology Journal. 2011;8(1):53.Google Scholar
JSC, T, Jothimani, D, Heneghan, MA, Harrison, PM. Non-invasive Assessment of Fibrosis in Liver Grafts due to Hepatitis C Virus Recurrence. Clinical Transplantation. 2011;25(3):345–51.Google Scholar
Demetris, A, Crawford, J, Minervini, M, Nalesnik, M, Ochoa, E, Randhawa, P, et al. Transplantation Pathology of the Liver. In: Odze, R, Goldblum, J, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. 2nd ed. Philadelphia: Saunders Elsevier; 2009. p. 1169–229.Google Scholar
Karimi, MH, Geramizadeh, B, Malek-Hosseini, SA. Tolerance Induction in Liver. International Journal of Organ Transplantation Medicine. 2015;6(2):4554.Google Scholar
Mastoridis, S, Martinez-Llordella, M, Sanchez-Fueyo, A. Emergent Transcriptomic Technologies and Their Role in the Discovery of Biomarkers of Liver Transplant Tolerance. Front Immunol. 2015;6:304.Google Scholar
Bohne, F, Londoño, MC, Benítez, C, Miquel, R, Martínez-Llordella, M, Russo, C, et al. HCV-induced Immune Responses Influence the Development of Operational Tolerance after Liver Transplantation in Humans. Sci Transl Med. 2014;6(242):242ra81.Google Scholar
Kamada, N. The Immunology of Experimental Liver Transplantation in the Rat. Immunology. 1985;55(3):369–89.Google Scholar
Feng, S, Ekong, UD, Lobritto, SJ, Demetris, AJ, Roberts, JP, Rosenthal, P, et al. Complete Immunosuppression Withdrawal and Subsequent Allograft Function among Pediatric Recipients of Parental Living Donor Liver Transplants. Jama. 2012;307(3):283–93.Google Scholar
Lerut, J, Sanchez-Fueyo, A. An Appraisal of Tolerance in Liver Transplantation. Am J Transplant. 2006;6(8):1774–80.Google Scholar
Murphy, MS, Harrison, R, Davies, P, Buckels, JA, Mayer, AD, Hubscher, S, et al. Risk Factors for Liver Rejection: Evidence to Suggest Enhanced Allograft Tolerance in Infancy. Arch Dis Child. 1996;75(6):502–6.Google Scholar
Talisetti, A, Hurwitz, M, Sarwal, M, Berquist, W, Castillo, R, Bass, D, et al. Analysis of Clinical Variables Associated with Tolerance in Pediatric Liver Transplant Recipients. Pediatric Transplantation. 2010;14(8):976–9.Google Scholar
Demetris, AJ, Isse, K. Tissue Biopsy Monitoring of Operational Tolerance in Liver Allograft Recipients. Curr Opin Organ Transplant. 2013;18(3):345–53.Google Scholar
Tisone, G, Orlando, G, Cardillo, A, Palmieri, G, Manzia, TM, Baiocchi, L, et al. Complete Weaning off Immunosuppression in HCV Liver Transplant Recipients Is Feasible and Favourably Impacts on the Progression of Disease Recurrence. Journal of Hepatology. 2006;44(4):702–9.Google Scholar
Wong, T, Nouri-Aria, KT, Devlin, J, Portmann, B, Williams, R. Tolerance and Latent Cellular Rejection in Long-term Liver Transplant Recipients. Hepatology. 1998;28(2):443–9.Google Scholar
Takatsuki, M, Uemoto, S, Inomata, Y, Egawa, H, Kiuchi, T, Fujita, S, et al. Weaning of Immunosuppression in Living Donor Liver Transplant Recipients. Transplantation. 2001;72(3):449–54.Google Scholar
Ramos, HC, Reyes, J, Abu-Elmagd, K, Zeevi, A, Reinsmoen, N, Tzakis, A, et al. – Weaning of Immunosuppression in Long-term Liver Transplant Recipients. Transplantation. 1995;59(2):212–7.Google Scholar
Strehlau, J, Pavlakis, M, Lipman, M, Shapiro, M, Vasconcellos, L, Harmon, W, et al. Quantitative Detection of Immune Activation Transcripts as a Diagnostic Tool in Kidney Transplantation. Proc Natl Acad Sci U S A. 1997;94(2):695700.Google Scholar
Sharma, VK, Bologa, RM, Li, B, Xu, GP, Lagman, M, Hiscock, W, et al. Molecular Executors of Cell Death–Differential Intrarenal Expression of Fas Ligand, Fas, Granzyme B, and Perforin during Acute and/or Chronic Rejection of Human Renal Allografts. Transplantation. 1996;62(12):1860–6.Google Scholar
Lipman, ML, Stevens, AC, Strom, TB. Heightened Intragraft CTL Gene Expression in Acutely Rejecting Renal Allografts. J Immunol. 1994;152(10):5120–7.Google Scholar
Suthanthiran, M. Molecular Analyses of Human Renal Allografts: Differential Intragraft Gene Expression during Rejection. Kidney Int Suppl. 1997;58:S1521.Google Scholar
Suthanthiran, M. Clinical Application of Molecular Biology: A Study of Allograft Rejection with Polymerase Chain Reaction. Am J Med Sci. 1997;313(5):264–7.Google Scholar
Strehlau, J, Pavlakis, M, Lipman, M, Maslinski, W, Shapiro, M, Strom, TB. The Intragraft Gene Activation of Markers Reflecting T-cell-activation and -Cytotoxicity Analyzed by Quantitative RT-PCR in Renal Transplantation. Clin Nephrol. 1996;46(1):30–3.Google Scholar
Adam, B, Mengel, M. Transplant Biopsy beyond Light Microscopy. BMC Nephrol. 2015;16:132.Google Scholar
Sis, B, Mengel, M, Haas, M, Colvin, RB, Halloran, PF, Racusen, LC, et al. BANFF ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of BANFF Working Groups. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2010;10(3):464–71.Google Scholar
Haas, M, Sis, B, Racusen, LC, Solez, K, Glotz, D, Colvin, RB, et al. BANFF 2013 Meeting Report: Inclusion of c4d-negative Antibody-mediated Rejection and Antibody-associated Arterial Lesions. Am J Transplant. 2014;14(2):272–83.Google Scholar
Shahzad, K, Fatima, A, Cadeiras, M, Wisniewski, N, Bondar, G, Cheng, R, et al. Challenges and Solutions in the Development of Genomic Biomarker Panels: A Systematic Phased Approach. Current Genomics. 2012;13(4):334–41.Google Scholar
Starling, RC, Pham, M, Valantine, H, Miller, L, Eisen, H, Rodriguez, ER, et al. Molecular Testing in the Management of Cardiac Transplant Recipients: Initial Clinical Experience. J Heart Lung Transplant. 25. United States2006. p. 1389–95.Google Scholar
Deng, MC, Eisen, HJ, Mehra, MR, Billingham, M, Marboe, CC, Berry, G, et al. Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling. Am J Transplant. 2006;6(1):150–60.Google Scholar
Deng, MC, Eisen, HJ, Mehra, MR. Methodological Challenges of Genomic Research–The CARGO Study. Am J Transplant. 6. Denmark2006. p. 1086–7.Google Scholar
Mehra, MR, Parameshwar, J. Gene Expression Profiling and Cardiac Allograft Rejection Monitoring: Is IMAGE Just a Mirage? J Heart Lung Transplant. 29. United States: Copyright 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved. 2010. p. 599602.Google Scholar
Pham, MX, Deng, MC, Kfoury, AG, Teuteberg, JJ, Starling, RC, Valantine, H. Molecular Testing for Long-term Rejection Surveillance in Heart Transplant Recipients: Design of the Invasive Monitoring Attenuation through Gene Expression (IMAGE) Trial. J Heart Lung Transplant. 2007;26(8):808–14.Google Scholar
Martinez-Llordella, M, Lozano, JJ, Puig-Pey, I, Orlando, G, Tisone, G, Lerut, J, et al. Using Transcriptional Profiling to Develop a Diagnostic Test of Operational Tolerance in Liver Transplant Recipients. J Clin Invest. 2008;118(8):2845–57.Google Scholar
Martinez-Llordella, M, Puig-Pey, I, Orlando, G, Ramoni, M, Tisone, G, Rimola, A, et al. Multiparameter Immune Profiling of Operational Tolerance in Liver Transplantation. Am J Transplant. 2007;7(2):309–19.Google Scholar
Kawasaki, M, Iwasaki, M, Koshiba, T, Fujino, M, Hara, Y, Kitazawa, Y, et al. Gene Expression Profile Analysis of the Peripheral Blood Mononuclear Cells from Tolerant Living-donor Liver Transplant Recipients. Int Surg. 2007;92(5):276–86.Google Scholar
Gehrau, R, Maluf, D, Archer, K, Stravitz, R, Suh, J, Le, N, et al. Molecular Pathways Differentiate Hepatitis C Virus (HCV) Recurrence from Acute Cellular Rejection in HCV Liver Recipients. Mol Med. 2011;17(7–8):824–33.Google Scholar
Gehrau, R, Mas, V, Archer, KJ, Maluf, D. Molecular Classification and Clonal Differentiation of Hepatocellular Carcinoma: The Step Forward for Patient Selection for Liver Transplantation. Expert rev. 2011;5(4):539–52.Google Scholar
von Ahlfen, S, Missel, A, Bendrat, K, Schlumpberger, M. Determinants of RNA Quality from FFPE Samples. PLoS One. 2007;2(12):e1261.Google Scholar
Kojima, K, April, C, Canasto-Chibuque, C, Chen, X, Deshmukh, M, Venkatesh, A, et al. Transcriptome Profiling of Archived Sectioned Formalin-fixed Paraffin-embedded (AS-FFPE) Tissue for Disease Classification. PLoS One. 2014;9(1):e86961.Google Scholar
Geiss, GK, Bumgarner, RE, Birditt, B, Dahl, T, Dowidar, N, Dunaway, DL, et al. Direct Multiplexed Measurement of Gene Expression with Color-coded Probe Pairs. Nature Biotechnology. 2008;26(3):317–25.Google Scholar
Tan, PS, Nakagawa, S, Goossens, N, Venkatesh, A, Huang, T, Ward, SC, et al. Clinicopathological Indices to Predict Hepatocellular Carcinoma Molecular Classification. Liver International: Official Journal of the International Association for the Study of the Liver. 2015.Google Scholar
Pfeffer, LM, Li, K, Fleckenstein, JF, Marion, TN, Diament, J, Yang, CH, et al. An Interferon Response Gene Signature Is Associated with the Therapeutic Response of Hepatitis C Patients. PLoS One. 2014;9(8):e104202.Google Scholar
Venkatesh, A, Sun, X, Hoshida, Y. Prognostic Gene Signature Profiles of Hepatitis C-Related Early-stage Liver Cirrhosis. Genom Data. 2014;2:361–2.Google Scholar
Shannon, CP, Balshaw, R, Ng, RT, Wilson-McManus, JE, Keown, P, McMaster, R, et al. Two-stage, in Silico Deconvolution of the Lymphocyte Compartment of the Peripheral Whole Blood Transcriptome in the Context of Acute Kidney Allograft Rejection. PLoS One. 2014;9(4):e95224.Google Scholar
Oghumu, S, Bracewell, A, Nori, U, Maclean, KH, Balada-Lasat, JM, Brodsky, S, et al. Acute Pyelonephritis in Renal Allografts: A New Role for MicroRNAs? Transplantation. 2014;97(5):559–68.Google Scholar
Spivey, TL, De Giorgi, V, Zhao, Y, Bedognetti, D, Pos, Z, Liu, Q, et al. The Stable Traits of Melanoma Genetics: An Alternate Approach to Target Discovery. BMC genomics. 2012;13:156.Google Scholar
Khatri, P, Roedder, S, Kimura, N, De Vusser, K, Morgan, AA, Gong, Y, et al. A Common Rejection Module (CRM) for Acute Rejection across Multiple Organs Identifies Novel Therapeutics for Organ Transplantation. J Exp Med. 2013;210(11):2205–21.Google Scholar
Isse, K, Lesniak, A, Grama, K, Roysam, B, Minervini, MI, Demetris, AJ. Digital Transplantation Pathology: Combining Whole Slide Imaging, Multiplex Staining and Automated Image Analysis. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2012;12(1):2737.Google Scholar
Grant, A, Neuberger, J. Guidelines on the Use of Liver Biopsy in Clinical Practice. British Society of Gastroenterology. Gut. 1999;45 Suppl 4:Iv1iv11.Google Scholar
Isse, K, Grama, K, Abbott, IM, Lesniak, A, Lunz, JG, Lee, WM, et al. Adding Value to Liver (and Allograft) Biopsy Evaluation Using a Combination of Multiplex Quantum Dot Immunostaining, High-resolution Whole-slide Digital Imaging, and Automated Image Analysis. Clin Liver Dis. 2010;14(4):669–85.Google Scholar
McGrath, MA, Morton, AM, Harnett, MM. Laser Scanning Cytometry: Capturing the Immune System in Situ. Methods Cell Biol. 2011;102:231–60.Google Scholar
Harnett, MM. Laser Scanning Cytometry: Understanding the Immune System in Situ. Nat Rev Immunol. 2007;7(11):897904.Google Scholar
Takahashi, H, Ruiz, P, Ricordi, C, Miki, A, Mita, A, Barker, S, et al. In Situ Quantitative Immunoprofiling of Regulatory T Cells Using Laser Scanning Cytometry. Transplantation Proceedings. 2009;41(1):238–9.Google Scholar
Halasz, T, Horvath, G, Kiss, A, Par, G, Szombati, A, Gelley, F, et al. Evaluation of Histological and Non-invasive Methods for the Detection of Liver Fibrosis: The Values of Histological and Digital Morphometric Analysis, Liver Stiffness Measurement and APRI Score. Pathology Oncology Research: POR. 2015.Google Scholar
Manousou, P, Burroughs, AK, Tsochatzis, E, Isgro, G, Hall, A, Green, A, et al. Digital Image Analysis of Collagen Assessment of Progression of Fibrosis in Recurrent HCV after Liver Transplantation. Journal of Hepatology. 2013;58(5):962–8.Google Scholar
Isgro, G, Calvaruso, V, Andreana, L, Luong, TV, Garcovich, M, Manousou, P, et al. The Relationship between Transient Elastography and Histological Collagen Proportionate Area for Assessing Fibrosis in Chronic Viral Hepatitis. J Gastroenterol. 2013;48(8):921–9.Google Scholar
Calvaruso, V, Dhillon, AP, Tsochatzis, E, Manousou, P, Grillo, F, Germani, G, et al. Liver Collagen Proportionate Area Predicts Decompensation in Patients with Recurrent Hepatitis C Virus Cirrhosis after Liver Transplantation. J Gastroenterol Hepatol. 2012;27(7):1227–32.Google Scholar
Vanderbeck, S, Bockhorst, J, Kleiner, D, Komorowski, R, Chalasani, N, Gawrieh, S. Automatic Quantification of Lobular Inflammation and Hepatocyte Ballooning in Nonalcoholic Fatty Liver Disease Liver Biopsies. Human Pathology. 2015;46(5):767–75.Google Scholar
Neil, DA, Roberts, IS, Bellamy, CO, Wigmore, SJ, Neuberger, JM. Improved Access to Histopathology Using a Digital System Could Increase the Organ Donor Pool and Improve Allocation. Transpl Int. 2014;27(8):759–64.Google Scholar
Mammas, CS, Lazaris, A, Kostopanagiotou, G, Lemonidou, C, Patsouris, E. The Digital, Microscopy in Organ Transplantation: Ergonomics of the Tele-pathological Evaluation of Renal and Liver Grafts. Studies in Health Technology and Informatics. 2015;213:287–90.Google Scholar
Jen, KY, Olson, JL, Brodsky, S, Zhou, XJ, Nadasdy, T, Laszik, ZG. Reliability of Whole Slide Images as a Diagnostic Modality for Renal Allograft Biopsies. Human Pathology. 2013;44(5):888–94.Google Scholar
Neil, DA, Demetris, AJ. Digital Pathology Services in Acute Surgical Situations. Br J Surg. 2014;101(10):1185–6.Google Scholar
Demetris, AJ, Crawford, JM, Minvervini, MI, Nalesnik, M, Ochoa, E, Randhawa, P, et al. Transplantation Pathology of the Liver. In: Odze, R, Goldblum, J, Crawford, JM, editors. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. (in press). Philadelphia: Saunders Elsever; 2008.Google Scholar
Quaglia, AF, Del Vecchio Blanco, G, Greaves, R, Burroughs, AK, Dhillon, AP. Development of Ductopaenic Liver Allograft Rejection Includes a “Hepatitic” Phase Prior to Duct Loss. Journal of Hepatology. 2000;33(5):773–80.Google Scholar
Kemmer, N, Kaiser, T, Zacharias, V, Neff, GW. Alpha-1-Antitrypsin Deficiency: Outcomes after Liver Transplantation. Transplantation Proceedings. 2008;40(5):1492–4.Google Scholar
Wolff, H, Otto, G, Giest, H. Liver Transplantation in Crigler-Najjar Syndrome. A Case Report. Transplantation. 1986;42(1):84.Google Scholar
Kaufman, SS, Wood, RP, Shaw, BW Jr., Markin, RS, Rosenthal, P, Gridelli, B, et al. Orthotopic Liver Transplantation for Type I Crigler-Najjar Syndrome. Hepatology. 1986;6(6):1259–62.Google Scholar
Yamashita, T, Ando, Y, Okamoto, S, Yohei, M, Hitahara, T, Ueda, M, et al. Effect of Liver Transplantation on the Survival of Patients with Ordinary Onset Familial Amyloid Polyneuropathy in Japan. Amyloid. 2011;18 Suppl 1:180–1.Google Scholar
Seth, AK, Badminton, MN, Mirza, D, Russell, S, Elias, E. Liver Transplantation for Porphyria: Who, When, and How? Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2007;13(9):1219–27.Google Scholar
Wahlin, S, Stal, P, Adam, R, Karam, V, Porte, R, Seehofer, D, et al. Liver Transplantation for Erythropoietic Protoporphyria in Europe. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011;17(9):1021–6.Google Scholar
Brandhagen, DJ. Liver Transplantation for Hereditary Hemochromatosis. Liver Transpl. 2001;7(8):663–72.Google Scholar
Maheshwari, A, Rankin, R, Segev, DL, Thuluvath, PJ. Outcomes of Liver Transplantation for Glycogen Storage Disease: A Matched-control Study and a Review of Literature. Clinical Transplantation. 2011.Google Scholar
Matern, D, Starzl, TE, Arnaout, W, Barnard, J, Bynon, JS, Dhawan, A, et al. Liver Transplantation for Glycogen Storage Disease Types I, III, and IV. Eur J Pediatr. 1999;158 Suppl 2:S438.Google Scholar
Gartner, JC Jr., Bergman, I, Malatack, JJ, Zitelli, BJ, Jaffe, R, Watkins, JB, et al. Progression of Neurovisceral Storage Disease with Supranuclear Ophthalmoplegia Following Orthotopic Liver Transplantation. Pediatrics. 1986;77(1):104–6.Google Scholar
Arnon, R, Annunziato, R, Miloh, T, Wasserstein, M, Sogawa, H, Wilson, M, et al. Liver Transplantation for Hereditary Tyrosinemia Type I: Analysis of the UNOS Database. Pediatric Transplantation. 2011;15(4):400–5.Google Scholar
Arnon, R, Annunziato, R, Schilsky, M, Miloh, T, Willis, A, Sturdevant, M, et al. Liver Transplantation for Children with Wilson Disease: Comparison of Outcomes between Children and Adults. Clinical Transplantation. 2011;25(1):E5260.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×